| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | heparin binding | TPSAB1 F2 F11 CCN4 PTPRS FBLN7 ADAMTS3 APOB ADAMTSL5 LPA TENM1 PCOLCE2 LTBP2 CTSG SERPINA5 | 2.18e-08 | 192 | 251 | 15 | GO:0008201 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | TPSAB1 F2 F11 CCN4 PTPRS ACAN LTBP4 FBLN7 ADAMTS3 APOB ADAMTSL5 LPA TENM1 PCOLCE2 LTBP2 CTSG SERPINA5 | 5.47e-08 | 268 | 251 | 17 | GO:0005539 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | MATN4 SSPOP FBLN2 PXDN HMCN2 ACAN SRPX LTBP4 LAMB3 HMCN1 PCOLCE2 LTBP1 LTBP2 MUC5AC | 1.18e-07 | 188 | 251 | 14 | GO:0005201 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | TPSAB1 MASP1 PRSS22 F2 F11 FAP KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 5.38e-06 | 190 | 251 | 12 | GO:0004252 |
| GeneOntologyMolecularFunction | endopeptidase activity | TPSAB1 MASP1 ADAM19 CASP14 PRSS22 PIDD1 CD46 F2 F11 FAP KLKB1 ADAMTS3 PRSS27 LPA TMPRSS2 ADAMTS14 CTSG TPSB2 | 9.22e-06 | 430 | 251 | 18 | GO:0004175 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.16e-05 | 85 | 251 | 8 | GO:0019199 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | TPSAB1 MASP1 PRSS22 F2 F11 FAP KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 1.28e-05 | 207 | 251 | 12 | GO:0008236 |
| GeneOntologyMolecularFunction | sulfur compound binding | TPSAB1 F2 F11 CCN4 PTPRS FBLN7 ADAMTS3 APOB ADAMTSL5 LPA TENM1 PCOLCE2 LTBP2 CTSG SERPINA5 | 1.57e-05 | 323 | 251 | 15 | GO:1901681 |
| GeneOntologyMolecularFunction | serine hydrolase activity | TPSAB1 MASP1 PRSS22 F2 F11 FAP KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 1.63e-05 | 212 | 251 | 12 | GO:0017171 |
| GeneOntologyMolecularFunction | microfibril binding | 3.82e-05 | 6 | 251 | 3 | GO:0050436 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.65e-04 | 65 | 251 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | calcium ion binding | MASP1 MATN4 F2 DYSF CPNE6 FBLN2 HMCN2 ACAN PLSCR3 LTBP4 NOTCH1 FBLN7 DUOX2 CUBN RGN EYS HMCN1 LTBP1 LTBP2 EML1 ATP2A1 CRB2 | 2.08e-04 | 749 | 251 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | VAPB TBC1D2 CD46 ITGA2B ITGA4 DSCAML1 CCN4 FAP FASN PLEC LTBP4 GCN1 NPHS1 EPS8L2 GSK3B EEF2 ICAM5 TENM1 PALLD | 2.19e-04 | 599 | 251 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | peptidase activity | TPSAB1 MASP1 ADAM19 CASP14 PRSS22 PIDD1 CD46 F2 F11 FAP KLKB1 ADAMTS3 AGBL3 PRSS27 LPA TMPRSS2 ADAMTS14 AGBL2 CTSG TPSB2 | 2.42e-04 | 654 | 251 | 20 | GO:0008233 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.13e-04 | 73 | 251 | 6 | GO:0050840 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 5.11e-04 | 13 | 251 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | lactoperoxidase activity | 9.29e-04 | 4 | 251 | 2 | GO:0140825 | |
| GeneOntologyMolecularFunction | protein antigen binding | 9.74e-04 | 16 | 251 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | quinone binding | 1.17e-03 | 17 | 251 | 3 | GO:0048038 | |
| GeneOntologyBiologicalProcess | regulation of fibrinolysis | 2.54e-06 | 19 | 250 | 5 | GO:0051917 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | TPSAB1 CYP1B1 MATN4 FAP PXDN ACAN KAZALD1 LTBP4 NOTCH1 SPINK5 ADAMTS3 LAMB3 HMCN1 ADAMTSL5 LPA ADAMTS14 CTSG | 3.88e-06 | 377 | 250 | 17 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | TPSAB1 CYP1B1 MATN4 FAP PXDN ACAN KAZALD1 LTBP4 NOTCH1 SPINK5 ADAMTS3 LAMB3 HMCN1 ADAMTSL5 LPA ADAMTS14 CTSG | 4.01e-06 | 378 | 250 | 17 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | TPSAB1 CYP1B1 MATN4 FAP PXDN ACAN KAZALD1 LTBP4 NOTCH1 SPINK5 ADAMTS3 LAMB3 HMCN1 ADAMTSL5 LPA ADAMTS14 CTSG | 4.16e-06 | 379 | 250 | 17 | GO:0045229 |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 9.85e-06 | 62 | 250 | 7 | GO:0050771 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 1.73e-05 | 5 | 250 | 3 | GO:0051919 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB4 MAG CYP1B1 IL12RB1 ADAM19 NCAM2 CD46 ITGA2B ITGA4 DCC UBASH3A DSCAML1 PTK7 MAGI2 HMCN2 PTPRS PKHD1 GNAS NOTCH1 NPHS1 FNDC3A EFNB3 HMCN1 ICAM5 TENM1 AJUBA CTSG PALLD CRB2 CD276 | 1.93e-05 | 1077 | 250 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of developmental growth | 2.35e-05 | 126 | 250 | 9 | GO:0048640 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 2.35e-05 | 29 | 250 | 5 | GO:0042730 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 3.63e-05 | 166 | 250 | 10 | GO:0061041 | |
| GeneOntologyBiologicalProcess | developmental growth | MAG EPPK1 ITGA4 DCC DYSF PTK7 MAGI2 CCN4 WWC2 CPNE6 PTPRS ARID5B GNAS PLEC NOTCH1 TRIM46 SEMA6C SEMA3F ATRN DUOX2 GSK3B MFSD2A EYS TIAM1 LPA PAX7 | 4.82e-05 | 911 | 250 | 26 | GO:0048589 |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 5.16e-05 | 173 | 250 | 10 | GO:0050768 | |
| GeneOntologyBiologicalProcess | response to wounding | MAG TPSAB1 EPPK1 MYLK MATN4 F2 DYSF UBASH3A F11 PTK7 CCN4 FAP PTPRS RIPOR1 GNAS PLEC KLKB1 DUOX2 LPA AJUBA CTSG | 5.74e-05 | 659 | 250 | 21 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 7.23e-05 | 217 | 250 | 11 | GO:1903034 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | MAG ITGA4 DCC PTK7 MAGI2 CPNE6 PTPRS NOTCH1 TRIM46 SEMA6C SEMA3F GSK3B TIAM1 | 7.84e-05 | 299 | 250 | 13 | GO:0060560 |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 8.65e-05 | 184 | 250 | 10 | GO:0051961 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 9.10e-05 | 38 | 250 | 5 | GO:0030517 | |
| GeneOntologyBiologicalProcess | wound healing | TPSAB1 EPPK1 MYLK F2 DYSF UBASH3A F11 PTK7 CCN4 FAP GNAS PLEC KLKB1 DUOX2 LPA AJUBA CTSG | 1.16e-04 | 493 | 250 | 17 | GO:0042060 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.23e-04 | 192 | 250 | 10 | GO:0050770 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.53e-04 | 126 | 250 | 8 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.89e-04 | 69 | 250 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.91e-04 | 98 | 250 | 7 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylcholine metabolic process | 1.98e-04 | 10 | 250 | 3 | GO:0150172 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.05e-04 | 70 | 250 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | MAG EPPK1 DCC CCN4 WWC2 CPNE6 PTPRS GNAS NOTCH1 TRIM46 SEMA6C SEMA3F ATRN GSK3B MFSD2A | 2.06e-04 | 421 | 250 | 15 | GO:0048638 |
| GeneOntologyBiologicalProcess | growth | MAG EPPK1 ITGA4 DCC F2 DYSF PTK7 MAGI2 CCN4 WWC2 CPNE6 PTPRS ARID5B KAZALD1 GNAS PLEC LTBP4 NOTCH1 TRIM46 SEMA6C SEMA3F ATRN EPM2A DUOX2 GSK3B MFSD2A EYS TIAM1 LPA PAX7 | 2.27e-04 | 1235 | 250 | 30 | GO:0040007 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.27e-04 | 169 | 250 | 9 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.39e-04 | 72 | 250 | 6 | GO:0050819 | |
| GeneOntologyBiologicalProcess | axon development | MAG NCAM2 PLXND1 ITGA4 DCC DSCAML1 TBC1D24 PTK7 HMCN2 PTPRS NOTCH1 TRIM46 SEMA6C SEMA3F LAMB3 GSK3B EFNB3 TIAM1 PALLD | 3.31e-04 | 642 | 250 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | lipoprotein transport | 3.43e-04 | 28 | 250 | 4 | GO:0042953 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 3.94e-04 | 29 | 250 | 4 | GO:0044872 | |
| GeneOntologyCellularComponent | extracellular matrix | TPSAB1 ADAM19 MATN4 F2 SSPOP CCN4 FBLN2 FCGBP PXDN HMCN2 OTOGL ACAN C1QC KAZALD1 SRPX LTBP4 NPHS1 FBLN7 ADAMTS3 LAMB3 MUC5B EYS HMCN1 ADAMTSL5 LPA PCOLCE2 LTBP1 LTBP2 ADAMTS14 CTSG MUC5AC SERPINA5 TPSB2 | 3.56e-12 | 656 | 251 | 33 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | TPSAB1 ADAM19 MATN4 F2 SSPOP CCN4 FBLN2 FCGBP PXDN HMCN2 OTOGL ACAN C1QC KAZALD1 SRPX LTBP4 NPHS1 FBLN7 ADAMTS3 LAMB3 MUC5B EYS HMCN1 ADAMTSL5 LPA PCOLCE2 LTBP1 LTBP2 ADAMTS14 CTSG MUC5AC SERPINA5 TPSB2 | 3.87e-12 | 658 | 251 | 33 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | TPSAB1 ADAM19 MATN4 F2 SSPOP FBLN2 PXDN HMCN2 ACAN C1QC KAZALD1 SRPX LTBP4 NPHS1 ADAMTS3 LAMB3 EYS HMCN1 ADAMTSL5 LPA PCOLCE2 LTBP1 LTBP2 CTSG SERPINA5 TPSB2 | 1.39e-09 | 530 | 251 | 26 | GO:0062023 |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 1.93e-04 | 10 | 251 | 3 | GO:0042564 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 3.47e-04 | 12 | 251 | 3 | GO:0031074 | |
| GeneOntologyCellularComponent | microfibril | 4.48e-04 | 13 | 251 | 3 | GO:0001527 | |
| Domain | EGF_2 | EPHB4 MASP1 ADAM19 MATN4 SSPOP FBLN2 HMCN2 C7 LTBP4 NOTCH1 ATRN FBLN7 NRG2 LAMB3 CUBN EYS HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 CRB2 EPHA1 | 1.33e-12 | 265 | 250 | 23 | PS01186 |
| Domain | EGF-like_CS | EPHB4 MASP1 ADAM19 MATN4 FBLN2 HMCN2 C7 LTBP4 NOTCH1 ATRN FBLN7 NRG2 LAMB3 CUBN EYS HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 CRB2 EPHA1 | 7.47e-12 | 261 | 250 | 22 | IPR013032 |
| Domain | IGc2 | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PTPRS KAZALD1 NPHS1 SEMA3F ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 FCRL4 PALLD CD276 | 7.50e-12 | 235 | 250 | 21 | SM00408 |
| Domain | Ig_sub2 | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PTPRS KAZALD1 NPHS1 SEMA3F ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 FCRL4 PALLD CD276 | 7.50e-12 | 235 | 250 | 21 | IPR003598 |
| Domain | Ig_I-set | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PTPRS CD101 KAZALD1 NPHS1 ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 PALLD | 1.08e-11 | 190 | 250 | 19 | IPR013098 |
| Domain | I-set | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PTPRS CD101 KAZALD1 NPHS1 ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 PALLD | 1.08e-11 | 190 | 250 | 19 | PF07679 |
| Domain | EGF_1 | MASP1 ADAM19 MATN4 SSPOP FBLN2 HMCN2 C7 LTBP4 NOTCH1 ATRN FBLN7 NRG2 LAMB3 CUBN EYS HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 CRB2 | 3.54e-11 | 255 | 250 | 21 | PS00022 |
| Domain | EGF_3 | MASP1 ADAM19 MATN4 SSPOP FBLN2 HMCN2 C7 LTBP4 NOTCH1 ATRN FBLN7 NRG2 CUBN EYS HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 CRB2 | 5.84e-11 | 235 | 250 | 20 | PS50026 |
| Domain | EGF-like_dom | MASP1 ADAM19 MATN4 FBLN2 FCGBP HMCN2 C7 LTBP4 NOTCH1 ATRN FBLN7 NRG2 CUBN EYS HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 CRB2 | 1.65e-10 | 249 | 250 | 20 | IPR000742 |
| Domain | Growth_fac_rcpt_ | EPHB4 MATN4 GPR179 CCN4 FBLN2 HMCN2 KAZALD1 LTBP4 NOTCH1 ATRN CUBN EYS HMCN1 LTBP1 LTBP2 EPHA1 | 3.29e-10 | 156 | 250 | 16 | IPR009030 |
| Domain | - | EPHB4 MAG IL12RB1 MYLK NCAM2 PLXND1 DCC DSCAML1 PTK7 PXDN PIGR PTPRS CD101 PKHD1 KAZALD1 TRIM46 NPHS1 SEMA3F FNDC3B EPM2A ROR1 MYOM3 SIGLEC14 NRG2 FNDC3A HMCN1 ICAM5 FCRLB FCRL4 PALLD EPHA1 CD276 | 3.44e-10 | 663 | 250 | 32 | 2.60.40.10 |
| Domain | Ig-like_fold | EPHB4 MAG IL12RB1 MYLK NCAM2 PLXND1 DCC DSCAML1 PTK7 PXDN HMCN2 PIGR PTPRS CD101 PKHD1 KAZALD1 TRIM46 NPHS1 SEMA3F FNDC3B EPM2A ROR1 MYOM3 SIGLEC14 NRG2 FNDC3A HMCN1 ICAM5 FCRLB FCRL4 PALLD EPHA1 CD276 | 4.04e-10 | 706 | 250 | 33 | IPR013783 |
| Domain | ASX_HYDROXYL | MASP1 MATN4 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 8.21e-10 | 100 | 250 | 13 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | MASP1 MATN4 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 1.71e-09 | 106 | 250 | 13 | IPR000152 |
| Domain | IG | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PIGR PTPRS CD101 KAZALD1 NPHS1 SEMA3F ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 FCRLB FCRL4 PALLD CD276 | 2.64e-09 | 421 | 250 | 24 | SM00409 |
| Domain | Ig_sub | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PIGR PTPRS CD101 KAZALD1 NPHS1 SEMA3F ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 FCRLB FCRL4 PALLD CD276 | 2.64e-09 | 421 | 250 | 24 | IPR003599 |
| Domain | EGF_Ca-bd_CS | MASP1 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 6.62e-09 | 97 | 250 | 12 | IPR018097 |
| Domain | EGF_CA | MASP1 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 8.39e-09 | 99 | 250 | 12 | PS01187 |
| Domain | EGF_CA | MASP1 MATN4 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 9.77e-09 | 122 | 250 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | MASP1 MATN4 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 1.19e-08 | 124 | 250 | 13 | IPR001881 |
| Domain | EGF | MATN4 GPR179 FBLN2 FCGBP LTBP4 NOTCH1 ATRN FBLN7 NRG2 CUBN EYS HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 CRB2 | 1.95e-08 | 235 | 250 | 17 | SM00181 |
| Domain | EGF_CA | MASP1 MATN4 FBLN2 HMCN2 LTBP4 NOTCH1 FBLN7 CUBN HMCN1 LTBP1 LTBP2 | 2.00e-08 | 86 | 250 | 11 | PF07645 |
| Domain | IG_LIKE | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PIGR PTPRS CD101 KAZALD1 NPHS1 SEMA3F ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 FCRLB FCRL4 PALLD CD276 | 5.08e-08 | 491 | 250 | 24 | PS50835 |
| Domain | Ig-like_dom | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PIGR PTPRS CD101 KAZALD1 NPHS1 SEMA3F ROR1 MYOM3 SIGLEC14 NRG2 HMCN1 ICAM5 FCRLB FCRL4 PALLD CD276 | 7.98e-08 | 503 | 250 | 24 | IPR007110 |
| Domain | TRYPSIN_HIS | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 1.34e-07 | 103 | 250 | 11 | IPR018114 |
| Domain | TRYPSIN_SER | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 1.80e-07 | 106 | 250 | 11 | PS00135 |
| Domain | TRYPSIN_HIS | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 1.98e-07 | 107 | 250 | 11 | PS00134 |
| Domain | CUB | 2.59e-07 | 49 | 250 | 8 | PF00431 | |
| Domain | fn3 | EPHB4 IL12RB1 MYLK NCAM2 DCC DSCAML1 PTPRS TRIM46 NPHS1 FNDC3B MYOM3 FNDC3A EPHA1 | 2.87e-07 | 162 | 250 | 13 | PF00041 |
| Domain | CUB | 3.04e-07 | 50 | 250 | 8 | SM00042 | |
| Domain | TRYPSIN_SER | 3.45e-07 | 90 | 250 | 10 | IPR033116 | |
| Domain | Peptidase_S1A | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 3.47e-07 | 113 | 250 | 11 | IPR001314 |
| Domain | TRYPSIN_DOM | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 4.14e-07 | 115 | 250 | 11 | PS50240 |
| Domain | - | 4.17e-07 | 52 | 250 | 8 | 2.60.120.290 | |
| Domain | Sushi | 4.17e-07 | 52 | 250 | 8 | PF00084 | |
| Domain | CUB | 4.86e-07 | 53 | 250 | 8 | PS01180 | |
| Domain | Tryp_SPc | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 4.93e-07 | 117 | 250 | 11 | SM00020 |
| Domain | CCP | 5.63e-07 | 54 | 250 | 8 | SM00032 | |
| Domain | Trypsin_dom | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 6.93e-07 | 121 | 250 | 11 | IPR001254 |
| Domain | Trypsin | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 6.93e-07 | 121 | 250 | 11 | PF00089 |
| Domain | SUSHI | 7.52e-07 | 56 | 250 | 8 | PS50923 | |
| Domain | Peptidase_S1_PA | TPSAB1 MASP1 PRSS22 F2 F11 KLKB1 PRSS27 LPA TMPRSS2 CTSG TPSB2 | 8.17e-07 | 123 | 250 | 11 | IPR009003 |
| Domain | Sushi_SCR_CCP_dom | 8.64e-07 | 57 | 250 | 8 | IPR000436 | |
| Domain | CUB_dom | 8.64e-07 | 57 | 250 | 8 | IPR000859 | |
| Domain | EGF | MATN4 NOTCH1 ATRN FBLN7 NRG2 CUBN EYS HMCN1 LTBP1 LTBP2 CRB2 | 1.04e-06 | 126 | 250 | 11 | PF00008 |
| Domain | FN3 | EPHB4 IL12RB1 MYLK NCAM2 DCC DSCAML1 PTPRS TRIM46 NPHS1 FNDC3B MYOM3 FNDC3A EPHA1 | 1.31e-06 | 185 | 250 | 13 | SM00060 |
| Domain | ig | MAG NCAM2 DSCAML1 PIGR PTPRS NPHS1 SEMA3F MYOM3 SIGLEC14 HMCN1 ICAM5 FCRL4 CD276 | 1.77e-06 | 190 | 250 | 13 | PF00047 |
| Domain | Immunoglobulin | MAG NCAM2 DSCAML1 PIGR PTPRS NPHS1 SEMA3F MYOM3 SIGLEC14 HMCN1 ICAM5 FCRL4 CD276 | 1.77e-06 | 190 | 250 | 13 | IPR013151 |
| Domain | FN3 | EPHB4 IL12RB1 MYLK NCAM2 DCC DSCAML1 PTPRS TRIM46 NPHS1 FNDC3B MYOM3 FNDC3A EPHA1 | 2.96e-06 | 199 | 250 | 13 | PS50853 |
| Domain | FN3_dom | EPHB4 IL12RB1 MYLK NCAM2 DCC DSCAML1 PTPRS TRIM46 NPHS1 FNDC3B MYOM3 FNDC3A EPHA1 | 5.06e-06 | 209 | 250 | 13 | IPR003961 |
| Domain | VWC | 1.04e-05 | 38 | 250 | 6 | SM00214 | |
| Domain | C8 | 1.43e-05 | 12 | 250 | 4 | PF08742 | |
| Domain | TIL | 1.43e-05 | 12 | 250 | 4 | PF01826 | |
| Domain | VWF_dom | 1.90e-05 | 42 | 250 | 6 | IPR001007 | |
| Domain | C8 | 2.04e-05 | 13 | 250 | 4 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 2.04e-05 | 13 | 250 | 4 | IPR014853 | |
| Domain | TSP_1 | 2.07e-05 | 63 | 250 | 7 | PF00090 | |
| Domain | TSP1_rpt | 2.54e-05 | 65 | 250 | 7 | IPR000884 | |
| Domain | TSP1 | 2.54e-05 | 65 | 250 | 7 | PS50092 | |
| Domain | TSP1 | 2.54e-05 | 65 | 250 | 7 | SM00209 | |
| Domain | TIL_dom | 2.82e-05 | 14 | 250 | 4 | IPR002919 | |
| Domain | VWF_type-D | 5.03e-05 | 16 | 250 | 4 | IPR001846 | |
| Domain | VWFD | 5.03e-05 | 16 | 250 | 4 | PS51233 | |
| Domain | VWD | 5.03e-05 | 16 | 250 | 4 | SM00216 | |
| Domain | VWD | 5.03e-05 | 16 | 250 | 4 | PF00094 | |
| Domain | Arm_3 | 7.97e-05 | 7 | 250 | 3 | PF16186 | |
| Domain | Importing_su_alpha | 7.97e-05 | 7 | 250 | 3 | IPR024931 | |
| Domain | TB | 7.97e-05 | 7 | 250 | 3 | PF00683 | |
| Domain | Arm_3 | 7.97e-05 | 7 | 250 | 3 | IPR032413 | |
| Domain | IBB | 7.97e-05 | 7 | 250 | 3 | PF01749 | |
| Domain | CTCK_1 | 8.27e-05 | 18 | 250 | 4 | PS01185 | |
| Domain | VWC_out | 1.04e-04 | 19 | 250 | 4 | SM00215 | |
| Domain | VWFC_1 | 1.11e-04 | 36 | 250 | 5 | PS01208 | |
| Domain | - | 1.26e-04 | 8 | 250 | 3 | 3.90.290.10 | |
| Domain | IBB | 1.26e-04 | 8 | 250 | 3 | PS51214 | |
| Domain | VWFC_2 | 1.44e-04 | 38 | 250 | 5 | PS50184 | |
| Domain | EGF_extracell | 1.48e-04 | 60 | 250 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.48e-04 | 60 | 250 | 6 | PF07974 | |
| Domain | Apple | 1.78e-04 | 2 | 250 | 2 | IPR000177 | |
| Domain | Pax7_C | 1.78e-04 | 2 | 250 | 2 | IPR022106 | |
| Domain | Pax7 | 1.78e-04 | 2 | 250 | 2 | PF12360 | |
| Domain | APPLE | 1.78e-04 | 2 | 250 | 2 | PS00495 | |
| Domain | APPLE | 1.78e-04 | 2 | 250 | 2 | SM00223 | |
| Domain | TB_dom | 1.88e-04 | 9 | 250 | 3 | IPR017878 | |
| Domain | Importin-a_IBB | 1.88e-04 | 9 | 250 | 3 | IPR002652 | |
| Domain | TB | 1.88e-04 | 9 | 250 | 3 | PS51364 | |
| Domain | Haem_peroxidase | 2.65e-04 | 10 | 250 | 3 | IPR010255 | |
| Domain | - | 2.65e-04 | 10 | 250 | 3 | 1.10.640.10 | |
| Domain | An_peroxidase | 2.65e-04 | 10 | 250 | 3 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.65e-04 | 10 | 250 | 3 | IPR019791 | |
| Domain | PEROXIDASE_3 | 2.65e-04 | 10 | 250 | 3 | PS50292 | |
| Domain | PSI | 2.93e-04 | 44 | 250 | 5 | IPR016201 | |
| Domain | Cys_knot_C | 3.18e-04 | 25 | 250 | 4 | IPR006207 | |
| Domain | CTCK_2 | 3.18e-04 | 25 | 250 | 4 | PS01225 | |
| Domain | PSI | 3.62e-04 | 46 | 250 | 5 | SM00423 | |
| Domain | cEGF | 3.72e-04 | 26 | 250 | 4 | PF12662 | |
| Domain | cEGF | 3.72e-04 | 26 | 250 | 4 | IPR026823 | |
| Domain | VWC | 4.98e-04 | 28 | 250 | 4 | PF00093 | |
| Domain | IGv | 5.04e-04 | 75 | 250 | 6 | SM00406 | |
| Domain | Quinoprotein_ADH-like_supfam | 7.02e-04 | 53 | 250 | 5 | IPR011047 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | TPSAB1 ADAM19 MATN4 ITGA2B ITGA4 FBLN2 PXDN PTPRS ACAN PLEC LTBP4 KLKB1 ADAMTS3 LAMB3 ICAM5 PCOLCE2 LTBP1 LTBP2 ADAMTS14 CTSG | 7.62e-09 | 300 | 197 | 20 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | TPSAB1 ADAM19 MATN4 ITGA2B ITGA4 FBLN2 PXDN ACAN LTBP4 KLKB1 ADAMTS3 ICAM5 LPA PCOLCE2 LTBP1 LTBP2 ADAMTS14 CTSG | 2.21e-08 | 258 | 197 | 18 | MM14572 |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 5.09e-06 | 69 | 197 | 8 | M16894 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 1.54e-05 | 58 | 197 | 7 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 1.73e-05 | 59 | 197 | 7 | M48343 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.41e-05 | 68 | 197 | 7 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | CYP1B1 ABCA3 SSPOP ACAN NOTCH1 OPLAH EPM2A ADAMTS3 MUC5B CUBN ADAMTSL5 ADAMTS14 MUC5AC | 5.03e-05 | 250 | 197 | 13 | M27554 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.12e-04 | 9 | 197 | 3 | M47699 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 2.66e-04 | 23 | 197 | 4 | M14766 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 2.66e-04 | 23 | 197 | 4 | MM14557 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 EPPK1 PLXND1 MBD6 MAST2 DYSF TBC1D24 FASN TNRC18 CLCN7 PTPRS SCN5A RIPOR1 KAZALD1 DTX2 PLEC HERC1 LTBP4 GCN1 IQGAP3 NOTCH1 SEMA6C SEMA3F EP400 NLRX1 MYOM3 LAMB3 UNC119 ADAMTSL5 DUSP16 DOT1L CD276 | 6.56e-11 | 1105 | 259 | 32 | 35748872 |
| Pubmed | ADAM19 MATN4 FBLN2 PXDN HMCN2 LTBP4 LAMB3 HMCN1 ADAMTSL5 LPA PCOLCE2 LTBP1 LTBP2 | 4.53e-10 | 167 | 259 | 13 | 22159717 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | MRPL43 MAST2 MTMR10 PTK7 WWC2 TRPM3 HERC1 FBLN7 ROR1 APOB AASDH EYS DUSP16 ERRFI1 KRTAP15-1 ALDH7A1 EPHA1 ILKAP | 3.42e-09 | 420 | 259 | 18 | 28065597 |
| Pubmed | PLXND1 ITGA2B F2 F11 FAP FCGBP PIGR PTPRS ACAN C7 KLKB1 ATRN APOB SERPINA5 | 9.99e-09 | 257 | 259 | 14 | 16335952 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TBC1D2 PIDD1 SRPRA GAL3ST2 CSMD2 SSPOP DSCAML1 CCN4 PARP4 FBXL7 TRPM3 ARID5B PKHD1 ATRN EDC3 TAS1R3 ROR1 MYOM3 LAMB3 SLC5A2 DUSP16 ERRFI1 | 4.29e-08 | 736 | 259 | 22 | 29676528 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | EPHB4 EPX F2 DYSF CPNE6 FASN FCGBP PXDN PIGR PTPRS C7 GNAS KLKB1 ATRN EPS8L2 MUC5B APOB CUBN EEF2 HMCN1 TMPRSS2 LTBP2 CTSG SERPINA5 ALDH7A1 CRB2 | 1.49e-07 | 1070 | 259 | 26 | 23533145 |
| Pubmed | 4.08e-07 | 3 | 259 | 3 | 12906867 | ||
| Pubmed | 8.59e-07 | 175 | 259 | 10 | 28071719 | ||
| Pubmed | VAPB MRPL43 GTF3C3 FASN RCC1L HMCN2 CLPB SIMC1 GNAS HSPA6 OPLAH KPNA3 KPNA4 SRSF1 NTPCR DUT TUT1 C1orf167 UBXN1 PPAT GSK3B TARDBP RNF220 EEF2 SF3B3 WDR87 INTS9 ALDH7A1 | 9.32e-07 | 1335 | 259 | 28 | 29229926 | |
| Pubmed | 1.47e-06 | 107 | 259 | 8 | 11347906 | ||
| Pubmed | 1.51e-06 | 75 | 259 | 7 | 20637190 | ||
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 15611103 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.62e-06 | 4 | 259 | 3 | 11104663 | |
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 9395085 | ||
| Pubmed | Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. | 1.62e-06 | 4 | 259 | 3 | 2844223 | |
| Pubmed | 1.63e-06 | 146 | 259 | 9 | 27068509 | ||
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 2.26e-06 | 29 | 259 | 5 | 12435358 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 2.81e-06 | 247 | 259 | 11 | 39238192 | |
| Pubmed | 2.88e-06 | 117 | 259 | 8 | 17145500 | ||
| Pubmed | 3.85e-06 | 162 | 259 | 9 | 25826454 | ||
| Pubmed | 3.85e-06 | 15 | 259 | 4 | 10964507 | ||
| Pubmed | 4.04e-06 | 5 | 259 | 3 | 19961612 | ||
| Pubmed | Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. | 4.04e-06 | 5 | 259 | 3 | 17981117 | |
| Pubmed | 7.67e-06 | 63 | 259 | 6 | 11572484 | ||
| Pubmed | Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. | 8.03e-06 | 6 | 259 | 3 | 8551560 | |
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 2064827 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 9548947 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 9603322 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 9593140 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 7585960 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 9918876 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 7859280 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 19349279 | ||
| Pubmed | Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. | 8.03e-06 | 6 | 259 | 3 | 9008157 | |
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 8876228 | ||
| Pubmed | Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. | 8.03e-06 | 6 | 259 | 3 | 7745752 | |
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 9557700 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 8041786 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 8041734 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 9303297 | ||
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 11904219 | ||
| Pubmed | Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. | 8.03e-06 | 6 | 259 | 3 | 8529100 | |
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 15037073 | ||
| Pubmed | Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. | 8.03e-06 | 6 | 259 | 3 | 8659115 | |
| Pubmed | 1.40e-05 | 7 | 259 | 3 | 10930463 | ||
| Pubmed | Purification and characterization of plasma protein C inhibitor. | 1.40e-05 | 7 | 259 | 3 | 2551064 | |
| Pubmed | Active nuclear import and cytoplasmic retention of activation-induced deaminase. | 1.40e-05 | 7 | 259 | 3 | 19412186 | |
| Pubmed | VAPB RALGAPA1 SRPRA MTMR10 ACSL3 WWC2 CLCN7 PTPRS HERC1 GCN1 HSPA6 NOTCH1 KPNA3 KPNA4 SHOC2 GSK3B TARDBP TIAM1 DUSP16 LTBP1 AJUBA ILKAP | 1.45e-05 | 1049 | 259 | 22 | 27880917 | |
| Pubmed | 1.54e-05 | 71 | 259 | 6 | 33541421 | ||
| Pubmed | VAPB EPHB4 EPPK1 ACSL3 FASN PXDN GNAS HSPA6 KPNA3 KPNA4 MARS2 ATRN EPS8L2 CALCOCO1 APOB UBXN1 SHOC2 PAPSS1 GSK3B TARDBP EEF2 MRPL38 PALLD AQR ALDH7A1 | 1.56e-05 | 1297 | 259 | 25 | 33545068 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | GTF3C3 FASN GCN1 HSPA6 KPNA3 EDC3 EP400 DUT TARDBP EEF2 SF3B3 ILKAP | 1.74e-05 | 357 | 259 | 12 | 37059091 |
| Pubmed | Ets1 is required for proper migration and differentiation of the cardiac neural crest. | 1.98e-05 | 22 | 259 | 4 | 20356956 | |
| Pubmed | An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A. | 2.22e-05 | 8 | 259 | 3 | 20818336 | |
| Pubmed | Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm. | 2.22e-05 | 8 | 259 | 3 | 20015032 | |
| Pubmed | 2.22e-05 | 8 | 259 | 3 | 8552640 | ||
| Pubmed | Essential roles of Meltrin beta (ADAM19) in heart development. | 2.22e-05 | 8 | 259 | 3 | 14975714 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 2.62e-05 | 47 | 259 | 5 | 14760718 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DYSF F11 PARP4 FASN FCGBP PIGR PKHD1 RIPOR1 NPHS1 ATRN EPS8L2 AHCTF1 AOX1 CUBN SLC5A2 EEF2 EYS TMPRSS2 CTSG SERPINA5 CRB2 | 2.82e-05 | 1016 | 259 | 21 | 19056867 |
| Pubmed | 3.12e-05 | 162 | 259 | 8 | 15174051 | ||
| Pubmed | VAPB EPPK1 CASP14 SRPRA ACSL3 FASN PIGR GCN1 KLC1 EEF2 LTBP1 | 3.18e-05 | 320 | 259 | 11 | 28685749 | |
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 10525473 | ||
| Pubmed | Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. | 3.32e-05 | 9 | 259 | 3 | 9463369 | |
| Pubmed | 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). | 3.32e-05 | 9 | 259 | 3 | 15057270 | |
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 10366569 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 12368302 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 11035935 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 9275210 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 10888652 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 8105392 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 11389849 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 12414950 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 9366553 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 10860744 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 15520281 | ||
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 21326825 | ||
| Pubmed | Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. | 3.32e-05 | 9 | 259 | 3 | 1631159 | |
| Pubmed | Characterization of the nuclear import pathway for HIV-1 integrase. | 3.32e-05 | 9 | 259 | 3 | 11278458 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CYP1B1 ETFDH FASTKD5 SRPRA STING1 SQOR PTK7 ACSL3 MAGI2 FAP FASN UBA7 FBLN2 GNAS PLEC PLIN4 SEMA3F FNDC3B FBLN7 SRSF1 DUT CPT2 EEF2 SF3B3 LTBP1 ADAMTS14 | 3.60e-05 | 1451 | 259 | 26 | 30550785 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CYP1B1 EPPK1 MRPL43 MAST2 GTF3C3 MAGI2 CCN4 PIGR PTPRS GNAS BCAR3 HERC1 GCN1 KLC3 KLC1 KPNA3 KPNA4 EDC3 SRSF1 UBXN1 GSK3B SF3B3 TIAM1 MAP3K21 | 3.77e-05 | 1284 | 259 | 24 | 17353931 |
| Pubmed | ADAM19 PDE9A NCAM2 NCKAP5 UBASH3A DSCAML1 MTMR10 MAGI2 UBA7 CLPB ARID5B PLEC LNX1 KPNA3 KPNA4 ATRN DALRD3 MSTO1 RNF220 EEF2 TIAM1 ATRNL1 SHARPIN MRPL38 | 3.82e-05 | 1285 | 259 | 24 | 35914814 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.60e-05 | 86 | 259 | 6 | 28327460 | |
| Pubmed | HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase. | 4.71e-05 | 10 | 259 | 3 | 9282826 | |
| Pubmed | 4.71e-05 | 10 | 259 | 3 | 14583634 | ||
| Pubmed | VAPB SRPRA CD46 PTK7 ACSL3 CLCN7 PLSCR3 GNAS NOTCH1 ROR1 EFNB3 TIAM1 CD276 | 5.51e-05 | 467 | 259 | 13 | 30194290 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 27070822 | ||
| Pubmed | HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. | 5.52e-05 | 2 | 259 | 2 | 31874109 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 28790171 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 21404224 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 37146737 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 25858550 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 5.52e-05 | 2 | 259 | 2 | 14988081 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 20188146 | ||
| Pubmed | NLRX1 attenuates endoplasmic reticulum stress via STING in cardiac hypertrophy. | 5.52e-05 | 2 | 259 | 2 | 39357547 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 17621824 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 24317696 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 5.52e-05 | 2 | 259 | 2 | 35776514 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 18824542 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 24327612 | ||
| Pubmed | Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity. | 5.52e-05 | 2 | 259 | 2 | 21933185 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | MAG MYLK NCAM2 DCC DSCAML1 PTK7 PXDN HMCN2 PTPRS CD101 KAZALD1 ROR1 MYOM3 NRG2 HMCN1 PALLD | 7.88e-12 | 161 | 183 | 16 | 593 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.42e-09 | 57 | 183 | 9 | 1179 | |
| GeneFamily | Fibronectin type III domain containing | EPHB4 IL12RB1 MYLK NCAM2 DCC DSCAML1 PTPRS NPHS1 FNDC3B MYOM3 FNDC3A EPHA1 | 8.44e-08 | 160 | 183 | 12 | 555 |
| GeneFamily | Fibulins | 6.89e-07 | 8 | 183 | 4 | 556 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 4.05e-06 | 4 | 183 | 3 | 628 | |
| GeneFamily | Immunoglobulin like domain containing | DCC DSCAML1 PTK7 HMCN2 CD101 NPHS1 SEMA3F MYOM3 ICAM5 FCRLB FCRL4 | 4.45e-06 | 193 | 183 | 11 | 594 |
| GeneFamily | Armadillo repeat containing|Importins | 7.44e-04 | 18 | 183 | 3 | 596 | |
| GeneFamily | Acyl-CoA synthetase family | 2.23e-03 | 26 | 183 | 3 | 40 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.74e-03 | 8 | 183 | 2 | 939 | |
| GeneFamily | Paired boxes | 3.50e-03 | 9 | 183 | 2 | 675 | |
| GeneFamily | Proteases, serine | 3.80e-03 | 63 | 183 | 4 | 738 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | MATN4 SSPOP CCN4 FBLN2 PXDN HMCN2 OTOGL SRPX LTBP4 FBLN7 LAMB3 HMCN1 PCOLCE2 LTBP1 LTBP2 | 8.48e-10 | 191 | 259 | 15 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | MATN4 SSPOP CCN4 FBLN2 PXDN HMCN2 SRPX LTBP4 FBLN7 LAMB3 EYS HMCN1 PCOLCE2 LTBP1 LTBP2 | 1.21e-09 | 196 | 259 | 15 | M3008 |
| Coexpression | NABA_MATRISOME | MASP1 ADAM19 MATN4 PLXND1 F2 SSPOP CCN4 FBLN2 PXDN HMCN2 OTOGL ACAN C1QC KAZALD1 SRPX LTBP4 SEMA6C SEMA3F FBLN7 ADAMTS3 NRG2 LAMB3 MUC5B HMCN1 ADAMTSL5 LPA PCOLCE2 LTBP1 LTBP2 ADAMTS14 CTSG MUC5AC SERPINA5 | 1.76e-09 | 1008 | 259 | 33 | MM17056 |
| Coexpression | NABA_MATRISOME | MASP1 ADAM19 MATN4 PLXND1 F2 SSPOP CCN4 FBLN2 PXDN HMCN2 ACAN C1QC KAZALD1 SRPX LTBP4 SEMA6C SEMA3F FBLN7 ADAMTS3 NRG2 LAMB3 MUC5B EYS HMCN1 ADAMTSL5 LPA PCOLCE2 LTBP1 LTBP2 ADAMTS14 CTSG MUC5AC SERPINA5 | 2.72e-09 | 1026 | 259 | 33 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | MATN4 SSPOP CCN4 FBLN2 PXDN HMCN2 OTOGL ACAN SRPX LTBP4 FBLN7 LAMB3 HMCN1 PCOLCE2 LTBP1 LTBP2 | 1.35e-08 | 270 | 259 | 16 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | MATN4 SSPOP CCN4 FBLN2 PXDN HMCN2 ACAN SRPX LTBP4 FBLN7 LAMB3 EYS HMCN1 PCOLCE2 LTBP1 LTBP2 | 1.75e-08 | 275 | 259 | 16 | M5884 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL | DYSF SQOR FCGBP TECPR2 PLEC BCAR3 BRD1 GCN1 FNDC3B EDC3 DUS4L JKAMP ADCK2 NOL9 PAPSS1 MSTO1 MSR1 ERRFI1 PALLD CD276 | 6.74e-08 | 476 | 259 | 20 | M45717 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | MAG PI4K2B CYP1B1 NHSL2 ITGA2B EPX DYSF ACAN RIPOR1 SRPX PLEC BCAR3 LNX1 RBM47 KLKB1 FBLN7 AOX1 NOL9 MSTO1 AGBL3 RNF220 PAX3 ATP2A1 CTSG | 1.12e-05 | 899 | 259 | 24 | M2242 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | MAG PI4K2B CYP1B1 NHSL2 ITGA2B EPX DYSF ACAN RIPOR1 SRPX PLEC BCAR3 LNX1 RBM47 KLKB1 FBLN7 AOX1 NOL9 MSTO1 AGBL3 RNF220 PAX3 ATP2A1 CTSG | 1.95e-05 | 930 | 259 | 24 | MM893 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 2.17e-05 | 85 | 259 | 7 | M45761 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | PDE9A MATN4 ITGA4 DYSF FBLN2 FBXL7 TRPM3 SCN5A GNAS BCAR3 NOTCH1 SEMA3F FBLN7 ROR1 IRF8 MAP3K6 RNF220 MFSD2A HMCN1 ADAMTSL5 ICAM5 SHISAL2B PAX3 MAP3K21 AJUBA PIK3R5 | 2.59e-05 | 1074 | 259 | 26 | M1941 |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | IL12RB1 FASTKD5 UBA7 CLPB PIGR FBLN7 OR11H4 SH3BP2 CUBN MRPL38 | 3.24e-05 | 200 | 259 | 10 | M9358 |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP | 3.24e-05 | 200 | 259 | 10 | M9660 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 4.90e-05 | 210 | 259 | 10 | M1303 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | VAPB PECR RTEL1 MAST2 F11 TECPR2 SRPX GNAS CALCOCO1 LAMB3 CPT2 PAPSS1 MAP3K6 EEF2 INTS9 LTBP1 ALDH7A1 | 5.50e-05 | 567 | 259 | 17 | M16909 |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 5.52e-05 | 213 | 259 | 10 | MM1125 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 7.97e-05 | 104 | 259 | 7 | M1318 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 9.54e-05 | 107 | 259 | 7 | MM1130 | |
| Coexpression | GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS | 1.16e-04 | 77 | 259 | 6 | M39137 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_UP | 1.24e-04 | 78 | 259 | 6 | M1308 | |
| Coexpression | NABA_ECM_REGULATORS | MASP1 ADAM19 F2 KAZALD1 ADAMTS3 ADAMTSL5 LPA ADAMTS14 CTSG SERPINA5 | 1.38e-04 | 238 | 259 | 10 | M3468 |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | PECR EPPK1 SLC12A8 STING1 FBXO17 CCN4 RBM47 FNDC3B NRG2 DUSP16 ALDH7A1 | 1.45e-04 | 287 | 259 | 11 | M6510 |
| Coexpression | DELYS_THYROID_CANCER_UP | CYP1B1 FJX1 PLXND1 PTK7 FAP PXDN SEMA3F ROR1 LAMB3 PAPSS1 MAP3K6 MSR1 TIAM1 TPSB2 | 1.53e-04 | 445 | 259 | 14 | M3645 |
| Coexpression | GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP | 1.54e-04 | 196 | 259 | 9 | M8428 | |
| Coexpression | NABA_ECM_REGULATORS | MASP1 ADAM19 F2 KAZALD1 ADAMTS3 ADAMTSL5 LPA ADAMTS14 CTSG SERPINA5 | 1.58e-04 | 242 | 259 | 10 | MM17062 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP | 1.79e-04 | 200 | 259 | 9 | M9314 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_DN | 1.79e-04 | 200 | 259 | 9 | M4863 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP | 1.79e-04 | 200 | 259 | 9 | M9883 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_DN | 1.79e-04 | 200 | 259 | 9 | M7212 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN | 1.79e-04 | 200 | 259 | 9 | M8575 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_DN | 1.79e-04 | 200 | 259 | 9 | M6385 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.79e-04 | 200 | 259 | 9 | M6789 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_DN | 1.79e-04 | 200 | 259 | 9 | M3079 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | VAPB KLHL3 PXDN DTX2 GNAS SEMA6C FNDC3B IRF8 GSK3B MFSD2A WDR87 PAX3 DOT1L PALLD | 1.79e-04 | 452 | 259 | 14 | M18685 |
| Coexpression | DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 1.92e-04 | 159 | 259 | 8 | M34031 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | PECR EPPK1 SLC12A8 STING1 FBXO17 CCN4 RBM47 FNDC3B NRG2 DUSP16 ALDH7A1 | 1.95e-04 | 297 | 259 | 11 | MM1003 |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 2.09e-04 | 30 | 259 | 4 | M47990 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.23e-04 | 206 | 259 | 9 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.39e-04 | 208 | 259 | 9 | MM581 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | MYLK NHSL2 NCAM2 CSMD2 MAGI2 CCN4 FAP FBXL7 C7 ROR1 HMCN1 LTBP1 LTBP2 PALLD | 1.15e-11 | 197 | 259 | 14 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | MYLK NHSL2 NCAM2 CSMD2 MAGI2 FAP FBXL7 PTPRS C7 ROR1 HMCN1 LTBP1 LTBP2 PALLD | 1.15e-11 | 197 | 259 | 14 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 DCC CSMD3 SSPOP DSCAML1 TRPM3 OTOGL PKHD1 MUC5B APOB HMCN1 TENM1 CSMD1 | 6.79e-11 | 184 | 259 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 DCC CSMD3 SSPOP DSCAML1 TRPM3 OTOGL PKHD1 MUC5B APOB HMCN1 TENM1 CSMD1 | 6.79e-11 | 184 | 259 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 DCC CSMD3 SSPOP DSCAML1 TRPM3 OTOGL PKHD1 MUC5B APOB HMCN1 TENM1 CSMD1 | 6.79e-11 | 184 | 259 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NOXA1 PRSS22 DSCAML1 WWC2 TRPM3 SH3RF2 PKHD1 EPS8L2 ROR1 LAMB3 ERRFI1 TMPRSS2 | 1.05e-09 | 186 | 259 | 12 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | MYLK NHSL2 NCAM2 CSMD2 CCN4 FAP FBXL7 C7 HMCN1 LTBP1 LTBP2 PALLD | 1.70e-09 | 194 | 259 | 12 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYLK NCAM2 FBLN2 FBXL7 PTPRS C7 LTBP4 AOX1 HMCN1 LTBP1 LTBP2 PALLD | 1.92e-09 | 196 | 259 | 12 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYLK NCAM2 FBLN2 FBXL7 PTPRS C7 LTBP4 AOX1 HMCN1 LTBP1 LTBP2 PALLD | 2.15e-09 | 198 | 259 | 12 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA3 NOXA1 DSCAML1 WWC2 TRPM3 SH3RF2 PKHD1 EPS8L2 ROR1 LAMB3 ICAM5 TMPRSS2 | 2.28e-09 | 199 | 259 | 12 | a270630626df614f8605abddb7dee7c4d74f6149 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | NOXA1 DSCAML1 WWC2 TRPM3 SH3RF2 PKHD1 EPS8L2 ROR1 LAMB3 ICAM5 ERRFI1 TMPRSS2 | 2.41e-09 | 200 | 259 | 12 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | EPHB4 PDE9A FAM110D NCAM2 FBLN2 FBXL7 PLEC SEMA3F FNDC3B HMCN1 LTBP1 PALLD | 2.41e-09 | 200 | 259 | 12 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | EPHB4 CYP1B1 NHSL2 PLXND1 DYSF KLHL3 FBLN2 SH3BP2 TIAM1 ACSM2A CRB2 | 2.71e-09 | 160 | 259 | 11 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | DSCAML1 MAGI2 TRPM3 PKHD1 NPHS1 ADAMTS3 ATRNL1 WSCD2 MAP3K21 ACSM2A CRB2 | 4.53e-09 | 168 | 259 | 11 | a086c306be430adf0632ba53e98cd8014d2de330 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NHSL2 PTK7 CCN4 FAP FBXL7 CD101 HMCN1 LTBP1 LTBP2 PAX7 PALLD | 7.37e-09 | 176 | 259 | 11 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NHSL2 PTK7 CCN4 FAP FBXL7 CD101 HMCN1 LTBP1 LTBP2 PAX7 PALLD | 7.37e-09 | 176 | 259 | 11 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PRSS22 DSCAML1 WWC2 TRPM3 SH3RF2 PKHD1 EPS8L2 ROR1 LAMB3 ERRFI1 TMPRSS2 | 9.86e-09 | 181 | 259 | 11 | b45b11428d13950369347e051d4d517efb2bd4fd |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ABCA3 NOXA1 PRSS22 TRPM3 SH3RF2 PKHD1 EPS8L2 ROR1 LAMB3 ERRFI1 TMPRSS2 | 1.11e-08 | 183 | 259 | 11 | ff6dde877659cde9daa3263db0932c9c9ef1adac |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 PKHD1 SH3BP2 AOX1 CUBN SLC5A2 ZNF804B ERRFI1 TENM1 ACSM2A | 1.38e-08 | 187 | 259 | 11 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 PKHD1 SH3BP2 AOX1 CUBN SLC5A2 ZNF804B ERRFI1 TENM1 ACSM2A | 1.38e-08 | 187 | 259 | 11 | f1356273bd3587b6883295edf15cb9cdb706c057 |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | CYP1B1 NCAM2 FBLN2 FBXL7 PXDN HMCN2 SRPX C7 LTBP4 LTBP1 LTBP2 | 1.46e-08 | 188 | 259 | 11 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.72e-08 | 191 | 259 | 11 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.72e-08 | 191 | 259 | 11 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYLK CSMD2 PTK7 CCN4 FAP FBXL7 HMCN1 LTBP1 LTBP2 ADAMTS14 PALLD | 1.82e-08 | 192 | 259 | 11 | 67e845e513e76e820f55e2f0d15eb16f2944d05c |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYLK NHSL2 NCAM2 FBXL7 PTPRS C7 AOX1 HMCN1 LTBP1 LTBP2 PALLD | 1.82e-08 | 192 | 259 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | NCAM2 FBLN2 FBXL7 PTPRS SRPX C7 LTBP4 FNDC3B AOX1 PCOLCE2 LTBP2 | 1.92e-08 | 193 | 259 | 11 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | NCAM2 FBLN2 FBXL7 PXDN HMCN2 PTPRS C7 LTBP4 AOX1 PCOLCE2 LTBP2 | 2.13e-08 | 195 | 259 | 11 | a78b605b49acd8c9d68716266ca269dafcd910b9 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYLK NHSL2 NCAM2 MAGI2 FBXL7 PTPRS C7 AOX1 HMCN1 LTBP1 PALLD | 2.25e-08 | 196 | 259 | 11 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.37e-08 | 197 | 259 | 11 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 2.50e-08 | 198 | 259 | 11 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | MYLK NHSL2 NCAM2 FBLN2 FBXL7 PTPRS C7 AOX1 HMCN1 LTBP1 LTBP2 | 2.50e-08 | 198 | 259 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | NOXA1 DSCAML1 WWC2 TRPM3 SH3RF2 PKHD1 EPS8L2 ROR1 LAMB3 ICAM5 TMPRSS2 | 2.50e-08 | 198 | 259 | 11 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 2.50e-08 | 198 | 259 | 11 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.63e-08 | 199 | 259 | 11 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.63e-08 | 199 | 259 | 11 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | NOXA1 DSCAML1 WWC2 TRPM3 PKHD1 KLC3 EPS8L2 ROR1 LAMB3 ICAM5 TMPRSS2 | 2.63e-08 | 199 | 259 | 11 | d43c605a4ff221cf78d91678c15d2ad20f831c7f |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 2.63e-08 | 199 | 259 | 11 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK NHSL2 NCAM2 FBXL7 PTPRS C7 AOX1 HMCN1 LTBP1 LTBP2 PALLD | 2.77e-08 | 200 | 259 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK CCN4 FAP FBLN2 FBXL7 RGN ATRNL1 TENM1 LTBP1 LTBP2 ADAMTS14 | 2.77e-08 | 200 | 259 | 11 | fb53be20392a8309a7393774c774a1b1aec6e676 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK NCAM2 CCN4 FAP FBLN2 RGN HMCN1 ATRNL1 TENM1 LTBP1 LTBP2 | 2.77e-08 | 200 | 259 | 11 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.77e-08 | 200 | 259 | 11 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK NHSL2 NCAM2 FBXL7 PTPRS C7 AOX1 HMCN1 LTBP1 LTBP2 PALLD | 2.77e-08 | 200 | 259 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.80e-08 | 161 | 259 | 10 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | NCAM2 FBLN2 FBXL7 PTPRS C7 LTBP4 DUOX2 ZNF804B ERRFI1 PCOLCE2 | 6.02e-08 | 169 | 259 | 10 | 6373562ab3b1765060212a6a53d6543e7e942e80 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-08 | 169 | 259 | 10 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | CYP1B1 FBLN2 HMCN2 SH3RF2 KAZALD1 LTBP4 SEMA3F MYOM3 HMCN1 CTSG | 8.81e-08 | 176 | 259 | 10 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 PKHD1 SH3BP2 AOX1 CUBN ZNF804B ERRFI1 CSMD1 ACSM2A | 9.29e-08 | 177 | 259 | 10 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PRSS22 DSCAML1 TRPM3 PKHD1 RBM47 EPS8L2 ROR1 LAMB3 ERRFI1 TMPRSS2 | 9.29e-08 | 177 | 259 | 10 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 SH3BP2 AOX1 MYOM3 CUBN MFSD2A ICAM5 ZNF804B ACSM2A | 1.03e-07 | 179 | 259 | 10 | d1ef7e1cb00336118e387b47f4f8120f53584391 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 OTOGL SH3BP2 CUBN SLC5A2 RGN ZNF804B ERRFI1 ACSM2A | 1.09e-07 | 180 | 259 | 10 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | NCKAP5 FBXO17 DSCAML1 TRPM3 PKHD1 AOX1 CUBN SLC5A2 TENM1 ACSM2A | 1.09e-07 | 180 | 259 | 10 | 358923e4228035a3e90e2957392089219e90dcd7 |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | NCAM2 FBLN2 FBXL7 PTPRS C7 AOX1 TIAM1 ZNF804B ERRFI1 PCOLCE2 | 1.15e-07 | 181 | 259 | 10 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 EPS8L2 CUBN SLC5A2 RGN ZNF804B ERRFI1 TENM1 ACSM2A | 1.27e-07 | 183 | 259 | 10 | facd6dbe0851b537d70a899ac7485714ab27d071 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.34e-07 | 184 | 259 | 10 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ABCA3 PRSS22 TRPM3 SH3RF2 PKHD1 ROR1 LAMB3 ERRFI1 TMPRSS2 MAP3K21 | 1.40e-07 | 185 | 259 | 10 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-07 | 185 | 259 | 10 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-07 | 186 | 259 | 10 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NCKAP5 TRPM3 PKHD1 SH3BP2 AOX1 CUBN SLC5A2 ZNF804B ERRFI1 ACSM2A | 1.48e-07 | 186 | 259 | 10 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ABCA3 NOXA1 PRSS22 TRPM3 PKHD1 ROR1 LAMB3 ARSD ERRFI1 TMPRSS2 | 1.55e-07 | 187 | 259 | 10 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.55e-07 | 187 | 259 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | NCKAP5 DSCAML1 TRPM3 PKHD1 ROR1 AOX1 MYOM3 CUBN SLC5A2 ACSM2A | 1.55e-07 | 187 | 259 | 10 | 738ec2611b4be6a08eedad16b57fba84e1f11fef |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 NCAM2 FBLN2 FBXL7 HMCN2 PTPRS LTBP4 ADAMTS3 PCOLCE2 LTBP1 | 1.63e-07 | 188 | 259 | 10 | ce85a56ac27a6432421dde93a1bafa8b943244b9 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 189 | 259 | 10 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CYP1B1 NCAM2 FBXL7 HMCN2 PTPRS C7 LTBP4 ADAMTS3 PCOLCE2 LTBP1 | 1.80e-07 | 190 | 259 | 10 | efb757f11c2809e66ddb48a5c84f5433f111cb7c |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-07 | 190 | 259 | 10 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.80e-07 | 190 | 259 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-07 | 190 | 259 | 10 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-07 | 191 | 259 | 10 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-07 | 191 | 259 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-07 | 191 | 259 | 10 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-07 | 191 | 259 | 10 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP1B1 WWC2 FAP FBLN2 SRPX FBLN7 ADAMTS3 HMCN1 ADAMTSL5 PCOLCE2 | 2.08e-07 | 193 | 259 | 10 | 59b8186d0221fba06a16157e9d148399ed801f38 |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP1B1 WWC2 FAP FBLN2 SRPX FBLN7 ADAMTS3 HMCN1 ADAMTSL5 PCOLCE2 | 2.08e-07 | 193 | 259 | 10 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP1B1 WWC2 FAP FBLN2 SRPX FBLN7 ADAMTS3 HMCN1 ADAMTSL5 PCOLCE2 | 2.08e-07 | 193 | 259 | 10 | 03678162648bd5b1d65a5450b60c8863edbf95c7 |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | EPHB4 CYP1B1 NHSL2 FAM110D PLXND1 FBXL7 SRPX SPINK5 SEMA3F HMCN1 | 2.29e-07 | 195 | 259 | 10 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.29e-07 | 195 | 259 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-07 | 195 | 259 | 10 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.40e-07 | 196 | 259 | 10 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.40e-07 | 196 | 259 | 10 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.40e-07 | 196 | 259 | 10 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | NCAM2 FBLN2 FBXL7 PTPRS C7 AOX1 TIAM1 ZNF804B ERRFI1 PCOLCE2 | 2.40e-07 | 196 | 259 | 10 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-07 | 197 | 259 | 10 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA3 NOXA1 CSMD2 SH3RF2 PKHD1 EPS8L2 LAMB3 ICAM5 ERRFI1 TMPRSS2 | 2.52e-07 | 197 | 259 | 10 | b94645d57efe8d9e032bffb8c89af1f425c6421e |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ABCA3 NOXA1 WWC2 PKHD1 EPS8L2 LAMB3 ICAM5 ERRFI1 TMPRSS2 MAP3K21 | 2.52e-07 | 197 | 259 | 10 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.64e-07 | 198 | 259 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.64e-07 | 198 | 259 | 10 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.76e-07 | 199 | 259 | 10 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-07 | 199 | 259 | 10 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-07 | 199 | 259 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.76e-07 | 199 | 259 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | EPHB4 CYP1B1 NHSL2 FAM110D PLXND1 FBLN2 SRPX SPINK5 SEMA3F HMCN1 | 2.76e-07 | 199 | 259 | 10 | 70e05d7c0c68c28754ce0e72434b205aed6287ae |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-07 | 200 | 259 | 10 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-07 | 200 | 259 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-07 | 200 | 259 | 10 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-07 | 200 | 259 | 10 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.90e-07 | 200 | 259 | 10 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-07 | 200 | 259 | 10 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-07 | 200 | 259 | 10 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.90e-07 | 200 | 259 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.90e-07 | 200 | 259 | 10 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| Drug | isocoumarin | 2.37e-07 | 39 | 256 | 7 | CID000068108 | |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A | CYP1B1 ADAM19 SRPRA UBA7 PIGR LTBP4 NLRX1 ADCK2 EFNB3 ICAM5 PAX3 ATP2A1 SERPINA5 | 3.91e-07 | 197 | 256 | 13 | 6842_UP |
| Drug | carboxyphosphamide | 6.82e-07 | 16 | 256 | 5 | CID000031515 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | MAG ABCA3 TBC1D2 ITGA2B DCC MAGI2 CLCN7 KPNA5 SRSF1 NRG2 ADCK2 APOB | 2.17e-06 | 194 | 256 | 12 | 4552_UP |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | PECR RTEL1 PRSS22 DYSF LTBP4 ATRN SRSF1 NLRX1 FNDC3A LTBP1 MUC5AC SERPINA5 | 2.17e-06 | 194 | 256 | 12 | 3193_DN |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | VAPB EPPK1 EPX FBXL7 CLCN7 RPS6KA6 CACNA1I SEMA3F SH3BP2 IRF8 NRG2 UNC119 | 2.42e-06 | 196 | 256 | 12 | 5232_UP |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; PC3; HT_HG-U133A | PRSS22 PLXND1 ITGA2B CHN2 CLCN7 TECPR2 ACAN RIPOR1 CACNA1I SPINK5 TRMT9B TMPRSS2 | 2.83e-06 | 199 | 256 | 12 | 6640_DN |
| Drug | Leupeptin hydrochloride | TPSAB1 CASP14 F2 CHN2 F11 PTK7 PIGR KLKB1 APOB CUBN PRSS27 TMPRSS2 CTSG TPSB2 | 3.24e-06 | 276 | 256 | 14 | CID000003910 |
| Drug | DB07444 | 7.20e-06 | 12 | 256 | 4 | CID006540255 | |
| Drug | HYCRON linker | 1.38e-05 | 5 | 256 | 3 | CID011069636 | |
| Drug | CNI-H0294 | 1.38e-05 | 5 | 256 | 3 | CID000073088 | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Up 200; 15.6uM; MCF7; HT_HG-U133A | ADAM19 PIDD1 DYSF TULP2 PTPRS PLSCR3 PLEC KPNA5 TRMT9B AOX1 SLC5A2 | 1.45e-05 | 196 | 256 | 11 | 3539_UP |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | CYP1B1 ABCA3 MAST2 RIPOR1 KAZALD1 KPNA5 ADAMTS3 ROR1 NRG2 UNC119 EPHA1 | 1.52e-05 | 197 | 256 | 11 | 6737_DN |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | VAPB RTEL1 PLXND1 CLCN7 TECPR2 RIPOR1 TTC22 TRMT9B EPM2A EFNB3 TMPRSS2 | 1.52e-05 | 197 | 256 | 11 | 6779_UP |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A | PDE9A CHN2 MAGI2 UBA7 FBXL7 FAM149A NPHS1 NLRX1 ADCK2 AGBL2 ALDH7A1 | 1.52e-05 | 197 | 256 | 11 | 6840_UP |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | IL12RB1 SLC12A8 CHN2 FAP GNAS DEAF1 NRG2 FNDC3A MSR1 ARSD MUC5AC | 1.60e-05 | 198 | 256 | 11 | 3342_UP |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | ADAM19 CHN2 CLCN7 PIGR TTC22 ADCK2 UBXN1 EFNB3 TENM1 TMPRSS2 MUC5AC | 1.60e-05 | 198 | 256 | 11 | 4462_UP |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; PC3; HG-U133A | PECR RTEL1 MAST2 KLHL3 ACAN PLSCR3 PLEC NOTCH1 KPNA4 DUS4L CPT2 | 1.60e-05 | 198 | 256 | 11 | 1924_UP |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | SLC12A8 MAST2 GFI1 RIPOR1 LTBP4 SPINK5 DEAF1 NRG2 MAP3K6 SLC5A2 ALDH7A1 | 1.67e-05 | 199 | 256 | 11 | 5540_UP |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | ITGA4 TRPM3 CACNA1I SPINK5 TRMT9B NEIL1 AOX1 LAMB3 MSR1 UNC119 ALDH7A1 | 1.75e-05 | 200 | 256 | 11 | 5513_UP |
| Drug | diisopropylfluorophosphate | TPSAB1 MASP1 PRSS22 F2 F11 PTK7 FAP KLKB1 RGN PRSS27 TMPRSS2 CTSG SERPINA5 TPSB2 | 1.80e-05 | 321 | 256 | 14 | CID000005936 |
| Drug | AC1NRA23 | 1.81e-05 | 73 | 256 | 7 | CID005287657 | |
| Drug | phosphoramide mustard | 1.96e-05 | 30 | 256 | 5 | CID000096356 | |
| Drug | AC1LA3FM | 2.74e-05 | 6 | 256 | 3 | CID000480797 | |
| Drug | malondialdehyde | 3.14e-05 | 213 | 256 | 11 | CID000010964 | |
| Drug | sulfonamide analog 1 | TPSAB1 CYP1B1 F2 F11 CCN4 KLKB1 GSK3B CTSG NLRP4 SERPINA5 TPSB2 | 3.14e-05 | 213 | 256 | 11 | CID005327336 |
| Drug | benzamidine | 4.46e-05 | 147 | 256 | 9 | CID000002332 | |
| Drug | AC1LTNWX | 4.73e-05 | 58 | 256 | 6 | CID001536427 | |
| Drug | AC1N17P1 | 4.76e-05 | 7 | 256 | 3 | CID003976779 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | IL12RB1 GFI1 MAGI2 CLCN7 PLEC TRMT9B SEMA3F CALCOCO1 ARSD TMPRSS2 | 5.36e-05 | 187 | 256 | 10 | 5204_UP |
| Drug | Fp-O | 5.69e-05 | 87 | 256 | 7 | CID000024267 | |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | EPHB4 CYP1B1 CD46 FJX1 PLXND1 SQOR RIPOR1 PLSCR3 EPS8L2 SH3BP2 | 6.40e-05 | 191 | 256 | 10 | 521_DN |
| Drug | A80a | 6.56e-05 | 20 | 256 | 4 | CID005487000 | |
| Drug | lauric acid | 6.99e-05 | 193 | 256 | 10 | CID000003893 | |
| Drug | CaCl2 | 7.08e-05 | 156 | 256 | 9 | CID000024854 | |
| Drug | NSC89634 | 7.28e-05 | 39 | 256 | 5 | CID000070877 | |
| Drug | Hcda | 7.55e-05 | 8 | 256 | 3 | CID005312573 | |
| Drug | ethylphenyl(2-formylethyl)phosphinate | 7.55e-05 | 8 | 256 | 3 | CID000151185 | |
| Drug | nitrefazole | 7.55e-05 | 8 | 256 | 3 | CID000071900 | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; MCF7; HT_HG-U133A | PIDD1 PTPRS CACNA1I SRPX KPNA5 NLRX1 ADCK2 SLC5A2 MSR1 SHARPIN | 7.62e-05 | 195 | 256 | 10 | 3543_UP |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | EPPK1 MYLK SLC12A8 CLCN7 SEMA3F SH3BP2 MUC5B MSR1 EFNB3 SERPINA5 | 7.62e-05 | 195 | 256 | 10 | 3941_DN |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | PIDD1 MAST2 GFI1 CLCN7 CACNA1I SPINK5 SEMA3F SH3BP2 ADCK2 ALDH7A1 | 7.62e-05 | 195 | 256 | 10 | 4170_DN |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; HL60; HT_HG-U133A | IL12RB1 TBC1D2 FJX1 KLHL3 TTC22 SPINK5 TRIM46 DEAF1 LTBP1 PALLD | 7.95e-05 | 196 | 256 | 10 | 2950_UP |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | CHN2 CACNA1I LTBP4 TRMT9B IRF8 NRG2 UBXN1 TMPRSS2 LTBP2 PIK3R5 | 7.95e-05 | 196 | 256 | 10 | 3847_UP |
| Drug | tranexamic acid | 8.28e-05 | 64 | 256 | 6 | CID000005526 | |
| Drug | Domperidone maleate; Down 200; 7.4uM; PC3; HT_HG-U133A | CYP1B1 IL12RB1 CACNA1I KAZALD1 SEMA3F EPM2A UBXN1 TMPRSS2 MUC5AC EPHA1 | 8.29e-05 | 197 | 256 | 10 | 4640_DN |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 8.29e-05 | 197 | 256 | 10 | 6792_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | RALGAPA1 TBC1D2 SLC12A8 ITGA2B DYSF KLHL3 PIGR CACNA1I KAZALD1 EFNB3 | 8.29e-05 | 197 | 256 | 10 | 1506_UP |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | ETFDH PIDD1 SRPRA KAZALD1 BRD1 ZNHIT2 EPM2A CPT2 SHARPIN EPHA1 | 8.29e-05 | 197 | 256 | 10 | 7093_UP |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | RALGAPA1 IL12RB1 DYSF PIGR CACNA1I ADCK2 MSR1 ARSD LTBP2 ALDH7A1 | 8.29e-05 | 197 | 256 | 10 | 2860_UP |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | VAPB CYP1B1 SRPRA SLC12A8 MAST2 PTPRS KAZALD1 PLSCR3 EP400 SHARPIN | 8.65e-05 | 198 | 256 | 10 | 4971_DN |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A | RALGAPA1 TBC1D2 PLXND1 FBXL7 CACNA1I KAZALD1 DEAF1 UNC119 EFNB3 SHARPIN | 8.65e-05 | 198 | 256 | 10 | 1541_UP |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | IL12RB1 TBC1D2 PIDD1 GFI1 MAGI2 TRPM3 LTBP4 IRF8 MUC5B AGBL3 | 8.65e-05 | 198 | 256 | 10 | 3797_UP |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | CLCN7 RIPOR1 KAZALD1 SPINK5 SEMA3F SRSF1 AOX1 LAMB3 EFNB3 PCOLCE2 | 8.65e-05 | 198 | 256 | 10 | 2651_DN |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | PIDD1 MAST2 ACAN PLSCR3 ZNHIT2 SH3BP2 UBXN1 SLC5A2 TMPRSS2 ALDH7A1 | 8.65e-05 | 198 | 256 | 10 | 7320_UP |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | CLCN7 RIPOR1 KAZALD1 SEMA3F AOX1 LAMB3 TUT1 UNC119 LTBP1 SERPINA5 | 8.65e-05 | 198 | 256 | 10 | 2640_DN |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | VAPB ABCA3 EPPK1 MAST2 FBXL7 TECPR2 SEMA3F SH3BP2 SLC5A2 EFNB3 | 8.65e-05 | 198 | 256 | 10 | 6742_DN |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | MAN2C1 SLC12A8 KAZALD1 PLSCR3 SPINK5 SEMA3F NRG2 FNDC3A UBXN1 TMPRSS2 | 8.65e-05 | 198 | 256 | 10 | 6270_UP |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | VAPB IL12RB1 PIDD1 SLC12A8 RIPOR1 KAZALD1 ZNHIT2 CALCOCO1 MAP3K6 EML1 | 8.65e-05 | 198 | 256 | 10 | 3289_DN |
| Drug | Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | PTK7 UBA7 CLCN7 TECPR2 ACAN KPNA5 SRSF1 SH3BP2 CALCOCO1 EFNB3 | 9.02e-05 | 199 | 256 | 10 | 6312_UP |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | SRPRA ITGA2B CLCN7 PTPRS ACAN PLEC SEMA3F FNDC3A EFNB3 AGBL2 | 9.02e-05 | 199 | 256 | 10 | 5927_UP |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | RALGAPA1 SLC12A8 PIGR CD101 SPINK5 TRMT9B ROR1 LTBP2 MUC5AC EPHA1 | 9.02e-05 | 199 | 256 | 10 | 5543_UP |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | RALGAPA1 ABCA3 MAN2C1 MAST2 PTPRS NOTCH1 SLC5A2 TIAM1 TENM1 EPHA1 | 9.02e-05 | 199 | 256 | 10 | 4523_DN |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | MAGI2 UBA7 KAZALD1 SEMA3F SH3BP2 MUC5B UBXN1 MSR1 EFNB3 MUC5AC | 9.02e-05 | 199 | 256 | 10 | 6287_UP |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | EPX UBA7 PTPRS CD101 TTC22 SPINK5 SH3BP2 AGBL3 SLC5A2 MUC5AC | 9.02e-05 | 199 | 256 | 10 | 5081_UP |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | VAPB IL12RB1 KPNA5 DEAF1 ADCK2 CPT2 UNC119 TMPRSS2 SERPINA5 AQR | 9.02e-05 | 199 | 256 | 10 | 6069_DN |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 9.02e-05 | 199 | 256 | 10 | 6513_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | ADAM19 TBC1D2 ACAN TTC22 TRMT9B SH3BP2 IRF8 DUOX2 UBXN1 EFNB3 | 9.02e-05 | 199 | 256 | 10 | 3774_UP |
| Drug | Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A | MAST2 TECPR2 TRIM46 TRMT9B SH3BP2 UBXN1 EFNB3 TIAM1 MUC5AC EPHA1 | 9.02e-05 | 199 | 256 | 10 | 2655_UP |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HG-U133A | MAST2 KLHL3 WWC2 SPINK5 SEMA3F SH3BP2 TUT1 SLC5A2 EFNB3 SHARPIN | 9.02e-05 | 199 | 256 | 10 | 315_DN |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A | RALGAPA1 MAST2 GFI1 TECPR2 PTPRS CACNA1I PLSCR3 LTBP4 EPM2A ATP2A1 | 9.40e-05 | 200 | 256 | 10 | 4377_DN |
| Drug | HA-1077 dihydrochloride; Up 200; 10uM; PC3; HG-U133A | 9.40e-05 | 200 | 256 | 10 | 436_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | RTEL1 ACAN SCN5A PLSCR3 KPNA5 SLC5A2 MSR1 UNC119 EFNB3 LTBP2 | 9.40e-05 | 200 | 256 | 10 | 6167_UP |
| Drug | Butacaine [149-16-6]; Up 200; 13uM; HL60; HT_HG-U133A | RTEL1 FAM110D CHN2 SCN5A KAZALD1 PLSCR3 SLC5A2 TMPRSS2 PALLD EPHA1 | 9.40e-05 | 200 | 256 | 10 | 2728_UP |
| Drug | Grgesp | 1.05e-04 | 42 | 256 | 5 | CID000492974 | |
| Drug | Methamphetamine | RALGAPA1 MYLK MRPL43 FJX1 MAST2 DYSF WWC2 FCGBP TRPM3 PTPRS SCN5A SRPX PLEC LTBP4 KPNA4 DEAF1 EP400 DUT ADCK2 TUT1 COQ10B CUBN MSTO1 ADAMTSL5 POLR3E ERRFI1 PCOLCE2 LTBP1 CSMD1 PIK3R5 PALLD SERPINA5 | 1.10e-04 | 1401 | 256 | 32 | ctd:D008694 |
| Drug | diguanylic acid | 1.12e-04 | 9 | 256 | 3 | CID000167640 | |
| Drug | Tat11 | 1.12e-04 | 9 | 256 | 3 | CID000480142 | |
| Drug | carbazeran | 1.26e-04 | 2 | 256 | 2 | CID000071983 | |
| Drug | 2bqv | 1.26e-04 | 2 | 256 | 2 | CID005327090 | |
| Drug | G 3012 | 1.27e-04 | 132 | 256 | 8 | CID000120739 | |
| Drug | AC1L8VEV | 1.39e-04 | 24 | 256 | 4 | CID000433433 | |
| Drug | aldophosphamide | 1.39e-04 | 24 | 256 | 4 | CID000107744 | |
| Drug | chrysene | CYP1B1 MYLK FAM110D NOXA1 DCC MTMR10 HMCN2 PIGR C7 GCN1 NOTCH1 MYOM3 COQ10B MSR1 TARDBP MFSD2A HMCN1 WSCD2 EML1 ADAMTS14 AGBL2 TPSB2 EPHA1 | 1.41e-04 | 871 | 256 | 23 | ctd:C031180 |
| Drug | Niacin | 1.82e-04 | 139 | 256 | 8 | ctd:D009525 | |
| Drug | funiferine N-oxide | 2.20e-04 | 49 | 256 | 5 | CID000191631 | |
| Drug | 2-vinyl benzaldehyde | 2.22e-04 | 108 | 256 | 7 | CID000039391 | |
| Drug | chondroitin sulfate | MAG NCAM2 GAL3ST2 ITGA4 F2 F11 FBLN2 ACAN ADAMTS3 FNDC3A PAPSS1 ADAMTSL5 LTBP1 CTSG | 2.62e-04 | 413 | 256 | 14 | CID000024766 |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.68e-04 | 186 | 256 | 9 | 5777_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.79e-04 | 187 | 256 | 9 | 3037_UP | |
| Drug | 4-amidinophenylpyruvic acid | 2.87e-04 | 12 | 256 | 3 | CID000151496 | |
| Drug | NSC-648146 | 2.87e-04 | 12 | 256 | 3 | CID000372649 | |
| Drug | Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 2.90e-04 | 188 | 256 | 9 | 4386_UP | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.90e-04 | 188 | 256 | 9 | 974_UP | |
| Drug | kessyl glycol diacetate | 2.92e-04 | 52 | 256 | 5 | CID000166927 | |
| Drug | S 2366 | 2.97e-04 | 29 | 256 | 4 | CID000126364 | |
| Drug | AC1L3NLD | 2.97e-04 | 29 | 256 | 4 | CID000092184 | |
| Drug | DETA | 3.10e-04 | 114 | 256 | 7 | CID000004284 | |
| Drug | sulfate | EPHB4 MAG NCAM2 GAL3ST2 F2 F11 PTK7 ACAN PLEC KLKB1 FBLN7 ADAMTS3 DUS4L AOX1 FNDC3A APOB PAPSS1 GSK3B MSR1 EFNB3 ARSD TIAM1 ADAMTSL5 PRSS27 LPA DOT1L CTSG MUC5AC SERPINA5 | 3.15e-04 | 1292 | 256 | 29 | CID000001117 |
| Drug | N-acetylhexosamine | MASP1 MAN2C1 NCAM2 CD46 ITGA2B GAL3ST2 ITGA4 EPX F11 FAP ACAN GNAS EFNB3 ICAM5 MUC5AC | 3.17e-04 | 472 | 256 | 15 | CID000000899 |
| Disease | Colorectal Carcinoma | CYP1B1 ABCA3 ADAM19 ETFDH CD46 DCC CSMD3 DSCAML1 FBLN2 PTPRS PKHD1 GNAS LAMB3 APOB CUBN KCNH4 TIAM1 ICAM5 TENM1 PIK3R5 EPHA1 | 7.85e-07 | 702 | 252 | 21 | C0009402 |
| Disease | tryptase beta-2 measurement | 4.98e-05 | 9 | 252 | 3 | EFO_0008306 | |
| Disease | hippocampal volume | EPPK1 ETFDH SQOR DSCAML1 GFI1 PLEC LNX1 MARS2 GSK3B SHARPIN EML1 | 5.48e-05 | 297 | 252 | 11 | EFO_0005035 |
| Disease | Primary congenital glaucoma | 7.27e-05 | 2 | 252 | 2 | C1533041 | |
| Disease | Congenital aneurysm of ascending aorta | 7.27e-05 | 2 | 252 | 2 | C0345050 | |
| Disease | facial morphology | 1.07e-04 | 55 | 252 | 5 | EFO_0004743 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.55e-04 | 32 | 252 | 4 | DOID:332 (is_implicated_in) | |
| Disease | Hamman-Rich syndrome | 2.09e-04 | 14 | 252 | 3 | C0085786 | |
| Disease | RHABDOMYOSARCOMA 2 | 2.17e-04 | 3 | 252 | 2 | 268220 | |
| Disease | 6-oxopiperidine-2-carboxylate measurement | 2.17e-04 | 3 | 252 | 2 | EFO_0800066 | |
| Disease | Alveolar rhabdomyosarcoma | 2.17e-04 | 3 | 252 | 2 | cv:C0206655 | |
| Disease | alveolar rhabdomyosarcoma (is_implicated_in) | 2.17e-04 | 3 | 252 | 2 | DOID:4051 (is_implicated_in) | |
| Disease | GLAUCOMA 3, PRIMARY INFANTILE, B | 2.17e-04 | 3 | 252 | 2 | 600975 | |
| Disease | GLAUCOMA 3, PRIMARY INFANTILE, B | 2.17e-04 | 3 | 252 | 2 | C1832977 | |
| Disease | Glaucoma 3, primary infantile, B | 2.17e-04 | 3 | 252 | 2 | cv:C1832977 | |
| Disease | Irritable Bowel Syndrome | 2.17e-04 | 3 | 252 | 2 | C0022104 | |
| Disease | brain measurement, neuroimaging measurement | SLC12A8 NCKAP5 DCC MBD6 TTC34 DSCAML1 CCN4 FBXL7 PLEC LNX1 ADAMTS3 ROR1 SEC14L6 EML1 | 3.01e-04 | 550 | 252 | 14 | EFO_0004346, EFO_0004464 |
| Disease | resting heart rate | 3.06e-04 | 149 | 252 | 7 | EFO_0004351 | |
| Disease | FEV/FEC ratio | CYP1B1 ABCA3 ADAM19 PDE9A DCC WWC2 FCGBP ACAN RIPOR1 HERC1 LNX1 LTBP4 KPNA3 FNDC3B SH3BP2 TUT1 HMCN1 LTBP1 LTBP2 CSMD1 AJUBA CRB2 CD276 | 3.81e-04 | 1228 | 252 | 23 | EFO_0004713 |
| Disease | Internal Carotid Artery Thrombosis | 4.31e-04 | 4 | 252 | 2 | C0750990 | |
| Disease | Common Carotid Artery Thrombosis | 4.31e-04 | 4 | 252 | 2 | C0750988 | |
| Disease | External Carotid Artery Thrombosis | 4.31e-04 | 4 | 252 | 2 | C0750989 | |
| Disease | Carotid Artery Thrombosis | 4.31e-04 | 4 | 252 | 2 | C0007274 | |
| Disease | Amphetamine-Related Disorders | 4.63e-04 | 75 | 252 | 5 | C0236733 | |
| Disease | Amphetamine Abuse | 4.63e-04 | 75 | 252 | 5 | C0236807 | |
| Disease | Amphetamine Addiction | 4.63e-04 | 75 | 252 | 5 | C0236804 | |
| Disease | anorectal malformation | 5.39e-04 | 19 | 252 | 3 | MONDO_0019938 | |
| Disease | osteoarthritis | 6.80e-04 | 222 | 252 | 8 | MONDO_0005178 | |
| Disease | relapsing-remitting multiple sclerosis (is_implicated_in) | 7.14e-04 | 5 | 252 | 2 | DOID:2378 (is_implicated_in) | |
| Disease | Alveolar rhabdomyosarcoma | 7.14e-04 | 5 | 252 | 2 | C0206655 | |
| Disease | scoliosis (implicated_via_orthology) | 7.14e-04 | 5 | 252 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | Anterior segment mesenchymal dysgenesis | 7.14e-04 | 5 | 252 | 2 | C1862839 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 7.14e-04 | 5 | 252 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | Hydrophthalmos | 7.14e-04 | 5 | 252 | 2 | C0020302 | |
| Disease | Idiopathic Pulmonary Fibrosis | 7.31e-04 | 21 | 252 | 3 | C1800706 | |
| Disease | neuroimaging measurement, brain volume measurement | 8.41e-04 | 286 | 252 | 9 | EFO_0004346, EFO_0006930 | |
| Disease | Malignant neoplasm of breast | EPHB4 CYP1B1 ABCA3 MAN2C1 DYSF FASN OTOGL BCAR3 ZNHIT2 NOTCH1 KPNA5 FNDC3B SRSF1 ROR1 IRF8 CUBN MAP3K6 EEF2 ICAM5 TENM1 | 9.83e-04 | 1074 | 252 | 20 | C0006142 |
| Disease | Diffuse interstitial pulmonary fibrosis | 1.07e-03 | 6 | 252 | 2 | cv:C0085786 | |
| Disease | retinitis pigmentosa | 1.07e-03 | 6 | 252 | 2 | MONDO_0019200 | |
| Disease | plasma serine protease inhibitor measurement | 1.07e-03 | 6 | 252 | 2 | EFO_0020642 | |
| Disease | serum selenium measurement | 1.10e-03 | 53 | 252 | 4 | EFO_0005266 | |
| Disease | corpus collosum mid-posterior volume measurement | 1.23e-03 | 25 | 252 | 3 | EFO_0010300 | |
| Disease | Profound Mental Retardation | 1.28e-03 | 139 | 252 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.28e-03 | 139 | 252 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.28e-03 | 139 | 252 | 6 | C0025363 | |
| Disease | Depressive Symptoms | 1.38e-03 | 26 | 252 | 3 | C0086132 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 1.48e-03 | 7 | 252 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | cancer antigen 15.3 measurement | 1.48e-03 | 7 | 252 | 2 | EFO_0010585 | |
| Disease | cortical thickness | SLC12A8 NCKAP5 PLXND1 MBD6 TTC34 MAST2 DYSF FBXL7 PKHD1 PLEC LNX1 TRMT9B FBLN7 ADAMTS3 ROR1 SHARPIN PAX7 EML1 AGBL2 CRB2 | 1.50e-03 | 1113 | 252 | 20 | EFO_0004840 |
| Disease | coronary artery disease (is_implicated_in) | 1.70e-03 | 100 | 252 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Scoliosis, unspecified | 1.97e-03 | 8 | 252 | 2 | C0036439 | |
| Disease | thrombin measurement | 1.97e-03 | 8 | 252 | 2 | EFO_0020768 | |
| Disease | factor XI measurement | 1.97e-03 | 8 | 252 | 2 | EFO_0004694 | |
| Disease | testis-expressed sequence 29 protein measurement | 1.97e-03 | 8 | 252 | 2 | EFO_0802125 | |
| Disease | common bile duct neoplasm (is_marker_for) | 1.97e-03 | 8 | 252 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Anterior segment dysgenesis | 1.97e-03 | 8 | 252 | 2 | cv:C1862839 | |
| Disease | white matter microstructure measurement | 2.05e-03 | 390 | 252 | 10 | EFO_0005674 | |
| Disease | neuroimaging measurement | SLC12A8 NCKAP5 PLXND1 DCC MBD6 TTC34 DYSF PTK7 CCN4 FBXL7 PKHD1 PLEC LNX1 ADAMTS3 ROR1 SEC14L6 PAX3 PAX7 EML1 | 2.22e-03 | 1069 | 252 | 19 | EFO_0004346 |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.32e-03 | 31 | 252 | 3 | C1335167 | |
| Disease | L-Selectin measurement | 2.32e-03 | 31 | 252 | 3 | EFO_0008202 | |
| Disease | osteoarthritis, knee | 2.44e-03 | 158 | 252 | 6 | EFO_0004616 | |
| Disease | corneal topography | 2.48e-03 | 109 | 252 | 5 | EFO_0004345 | |
| Disease | hemangiopericytoma (is_marker_for) | 2.51e-03 | 9 | 252 | 2 | DOID:264 (is_marker_for) | |
| Disease | familial Mediterranean fever (is_marker_for) | 2.51e-03 | 9 | 252 | 2 | DOID:2987 (is_marker_for) | |
| Disease | Disorder of fatty acid metabolism | 2.51e-03 | 9 | 252 | 2 | cv:C0268634 | |
| Disease | Glaucoma | 2.51e-03 | 9 | 252 | 2 | C0017601 | |
| Disease | Complement deficiency disease | 2.78e-03 | 33 | 252 | 3 | C0272242 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 3.12e-03 | 10 | 252 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 3.12e-03 | 10 | 252 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 3.12e-03 | 10 | 252 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 3.12e-03 | 10 | 252 | 2 | C1449842 | |
| Disease | transmembrane glycoprotein NMB measurement | 3.12e-03 | 10 | 252 | 2 | EFO_0008303 | |
| Disease | lactose measurement | 3.12e-03 | 10 | 252 | 2 | EFO_0010507 | |
| Disease | Pseudohypoaldosteronism, Type I | 3.12e-03 | 10 | 252 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 3.12e-03 | 10 | 252 | 2 | C0033805 | |
| Disease | SAPHO syndrome | 3.29e-03 | 35 | 252 | 3 | EFO_1001164 | |
| Disease | heart rate | 3.33e-03 | 225 | 252 | 7 | EFO_0004326 | |
| Disease | coronary artery disease | CYP1B1 ADAM19 TTC34 PTK7 FAP TRPM3 PKHD1 LNX1 RBM47 FNDC3B ADAMTS3 DUS4L DUOX2 APOB MSR1 SF3B3 LPA EML1 NLRP4 PALLD | 3.36e-03 | 1194 | 252 | 20 | EFO_0001645 |
| Disease | 3-methylglutarylcarnitine (2) measurement | 3.80e-03 | 11 | 252 | 2 | EFO_0800074 | |
| Disease | psychosocial stress measurement | 3.80e-03 | 11 | 252 | 2 | EFO_0006783 | |
| Disease | smoking status measurement, forced expiratory volume | 3.80e-03 | 11 | 252 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | pulmonary fibrosis | 3.80e-03 | 11 | 252 | 2 | EFO_0009448 | |
| Disease | peak expiratory flow | CYP1B1 ADAM19 DYSF UBA7 ACAN BRD1 LTBP4 FNDC3B EYS AGBL2 AJUBA | 3.92e-03 | 498 | 252 | 11 | EFO_0009718 |
| Disease | Hypercholesterolemia | 4.48e-03 | 39 | 252 | 3 | C0020443 | |
| Disease | Thromboembolism | 4.53e-03 | 12 | 252 | 2 | C0040038 | |
| Disease | Nonsyndromic Deafness | 5.17e-03 | 81 | 252 | 4 | C3711374 | |
| Disease | retinal vasculature measurement | NCKAP5 DCC DYSF DSCAML1 PXDN KPNA4 EYS ZNF804B LTBP2 PALLD CRB2 | 5.17e-03 | 517 | 252 | 11 | EFO_0010554 |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 5.33e-03 | 13 | 252 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Connective Tissue Diseases | 5.33e-03 | 13 | 252 | 2 | C0009782 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 5.33e-03 | 13 | 252 | 2 | cv:C4273714 | |
| Disease | age at menarche | ETFDH DSCAML1 PTK7 MAGI2 KLHL3 TRPM3 SEMA6C FNDC3B FNDC3A ATRNL1 WSCD2 CSMD1 | 5.34e-03 | 594 | 252 | 12 | EFO_0004703 |
| Disease | Hodgkins lymphoma | 5.40e-03 | 82 | 252 | 4 | EFO_0000183 | |
| Disease | corneal resistance factor | MTMR10 FBLN2 TRPM3 ARID5B KAZALD1 LNX1 FNDC3B FBLN7 DEAF1 LTBP1 | 5.69e-03 | 451 | 252 | 10 | EFO_0010067 |
| Disease | aortic measurement | 6.02e-03 | 251 | 252 | 7 | EFO_0020865 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 6.18e-03 | 14 | 252 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 6.18e-03 | 14 | 252 | 2 | cv:C2931907 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.18e-03 | 14 | 252 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Fatty Liver | 6.92e-03 | 88 | 252 | 4 | C0015695 | |
| Disease | Steatohepatitis | 6.92e-03 | 88 | 252 | 4 | C2711227 | |
| Disease | descending aortic diameter | 6.92e-03 | 88 | 252 | 4 | EFO_0021788 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTVQCRSAQQPRRAY | 1431 | Q68DN1 | |
| RRALLGRYCQQTPAP | 146 | B3EWF7 | |
| GRYCQQTPAPGAERE | 151 | B3EWF7 | |
| VNERRCSQAPVYGRD | 1756 | Q96L91 | |
| GEVYRGTLRLPSQDC | 636 | P21709 | |
| PGCTRRPLNIYGDVE | 391 | O95696 | |
| ENREPVGSGCVAQVY | 201 | Q7Z695 | |
| DGVIVGNYRCSLAGR | 406 | Q8NEM8 | |
| PCLRRTRQNLYQDVG | 101 | Q5SNV9 | |
| LGCYGNNTLRTPNID | 56 | P51689 | |
| SIVRFECNPGYLLQG | 1761 | Q96PZ7 | |
| VLSFQCEPGYTLQGR | 1936 | Q96PZ7 | |
| EFNIGDIVRYRCLPG | 2311 | Q7Z408 | |
| RDTVVYQCNPGFRLI | 2836 | Q7Z407 | |
| YQCNPGFRLIGSSVR | 2841 | Q7Z407 | |
| GRGEVITTYCPANNE | 61 | P49419 | |
| VRCYVGNRRPISQQS | 231 | O75815 | |
| LDRLYAQRPAGFGCQ | 211 | Q96IF1 | |
| RQIQCRGTHVYRGPE | 601 | Q9H013 | |
| GAQAPVRNGRYLASC | 26 | Q9H8M1 | |
| RANDIINSSGYRIGP | 461 | Q08AH3 | |
| PGNTLEVRESGLYRC | 71 | Q96PJ5 | |
| PRGEPQDGLYCIRNS | 476 | P78314 | |
| AGGINRTKYPILCQA | 71 | Q86SQ6 | |
| VGKVRQRIGYCPQFD | 1451 | Q99758 | |
| QGIREIGLYCQPGID | 56 | Q4L235 | |
| RPFIEQVGLVYVRGC | 581 | O60306 | |
| VLGANGTYSCLVRNP | 211 | Q5ZPR3 | |
| GANGTYSCLVRNPVL | 431 | Q5ZPR3 | |
| DRPRYAIGVCAQVVG | 106 | O95388 | |
| QAAGYELCGVLSRPS | 716 | Q8TEK3 | |
| GAPEGVIDRCNYVRV | 516 | O14983 | |
| QPLRQECVYTGGVTG | 146 | Q8WXS8 | |
| GNLCRCTGYRPIIDA | 146 | Q06278 | |
| IGCNVSSYPGRNARE | 621 | P23786 | |
| SGVIASYRRCLPQIQ | 391 | O95741 | |
| GGTPEQIRYLVALGC | 411 | O15131 | |
| YSNIRAAGGAVCEQP | 2341 | Q9HC84 | |
| RGRLEVPCQSLEAYA | 5321 | Q9HC84 | |
| NIRGCLGIGRLEDQY | 421 | Q96I51 | |
| LNNYEIRPGRLLGVC | 131 | A0AV96 | |
| QCRGAGGRPVLYQVV | 391 | Q86UR1 | |
| ALTVRNGGNVLVPCY | 286 | Q9NV88 | |
| PCYRGQLAASVLRQI | 61 | Q86XR2 | |
| ILCRYQETGSIRPGA | 86 | P23759 | |
| NQYRCICPPGRTGNR | 156 | Q53RD9 | |
| NECELYGQEGRPRLC | 226 | Q53RD9 | |
| DGGLPQRFCIRYEAL | 966 | O60500 | |
| CKIQDDVRGYTNGPI | 581 | Q5SY16 | |
| RLQPGDIGIYRCSAR | 201 | P43146 | |
| QRCVREGAVLYISPS | 26 | Q96DN6 | |
| GNGAIIYAVRCNPLL | 51 | Q8NGC9 | |
| LGNIIGDGPQCRDYV | 181 | O00505 | |
| GDGPQCRDYVISLGV | 186 | O00505 | |
| GLCGRYLERQLAPEN | 116 | Q8N239 | |
| GQPIQYARSTCEAGV | 551 | Q15746 | |
| LQGYTGPRCEIDVNE | 441 | P46531 | |
| YRCLGRNALGQVEAP | 251 | Q96I82 | |
| EGLSYRCLCPEGRQL | 356 | O95460 | |
| VPIGQSVNLVLCRGY | 496 | Q86UL8 | |
| QAPPRVICTARNLYG | 481 | P20916 | |
| RETCPYIRDPLNGQA | 96 | P15529 | |
| PVYGFRGCILDLQVN | 2301 | Q5T1H1 | |
| PGRGPCVLQEYQQFR | 131 | Q96FI4 | |
| RTYEVCDVQRAPGQA | 56 | P54760 | |
| VQSYRPCGALERGAG | 136 | Q99684 | |
| RGQNTAVPGCRLVSY | 666 | A5PLN7 | |
| QCVPLESQGFVLGRY | 301 | Q6PRD1 | |
| LRQQRSGPLEACYGE | 696 | Q9NXD2 | |
| CLQRSDPALYGGVQA | 276 | Q5IJ48 | |
| RGFPRQCYLPDNAQG | 531 | Q86UW9 | |
| NGILFCTRENDPIRG | 306 | Q9NQ38 | |
| LICTRENNPVRGPYG | 861 | Q9NQ38 | |
| RELRELYVQGGGDCP | 101 | Q8NDA2 | |
| IIPTDGGRYQCVASN | 576 | Q8NDA2 | |
| EVENRYQGNPLRGTC | 1141 | O75882 | |
| NLLSQACGESRYQPG | 1276 | Q15751 | |
| CAERNRPGVYISLSA | 266 | Q9GZN4 | |
| RQLGSRPRFVYEACG | 196 | P0C7V8 | |
| GAVGCRLQRRVPANY | 51 | Q9NRD8 | |
| LIYSSRDCQPLQGGS | 431 | P51798 | |
| RCLSYGGTSQLRVPE | 961 | O95382 | |
| YDCLQGGFVRGRVPA | 71 | P98095 | |
| ETCNRYELRSGAGQP | 101 | Q9NRY6 | |
| ACDYGNNIRTVARVP | 636 | Q9Y4D7 | |
| RVLAPGIYVCNATNR | 636 | Q9UMF0 | |
| NSQGRLPDGRVVLCF | 336 | Q02556 | |
| DDYAQLCNIPVTGRR | 1571 | Q14766 | |
| LCNIPVTGRRQPYGR | 1576 | Q14766 | |
| CPDVLYRTGRTLHGQ | 46 | Q9BUK6 | |
| ANIYPRGFVNCSRIP | 691 | P11678 | |
| CSGIRINCVAPGVIY | 191 | Q9BY49 | |
| RPREPQGCYQEGQRI | 131 | O76083 | |
| SVGSCVPLERNQRYI | 181 | O14511 | |
| LANAQGTRGFPIVYC | 31 | Q9UQ05 | |
| IVEGTPAYNDGRIRC | 671 | Q8TBB1 | |
| PAYNDGRIRCGDILL | 676 | Q8TBB1 | |
| PGKRECRVGQYVVDL | 71 | Q9BSD7 | |
| AQQGGYEIPARLRTL | 196 | Q6P597 | |
| VAVNVAPGRLCAGRY | 2491 | Q92616 | |
| QLRGENGLLLTPCYT | 571 | Q9UK32 | |
| IRSLCDALNYPAGNV | 711 | Q96MN2 | |
| GANGTIERRVYPCSP | 1306 | P98088 | |
| GPCLRNRYGEDVRSA | 381 | Q96GN5 | |
| AGRIYLCDIGIPQQV | 471 | Q96F86 | |
| PNERGDQYCGGLLDR | 146 | Q9UKZ9 | |
| NPDACGRRVQTVVLY | 151 | Q86UT6 | |
| CGDTRPNRVYGLTAA | 191 | Q8NH57 | |
| GQYPSICPRLELGND | 1681 | Q9UKK3 | |
| TDIQIALPSGCYGRV | 156 | P33316 | |
| VPFRDLQCALYNGRP | 101 | Q6ZMM2 | |
| LQCALYNGRPVLGTQ | 106 | Q6ZMM2 | |
| LRSRSGQAGYVPCNI | 531 | Q9H6S3 | |
| GQAGYVPCNILGEAR | 536 | Q9H6S3 | |
| AVALRGVVPDCANGY | 636 | Q86VI3 | |
| PNCGGNLLGVRTVYV | 316 | P16112 | |
| RQRTRGCSDPVPQYG | 4721 | Q96RW7 | |
| VRVGQVVCRSLGYPG | 381 | P21757 | |
| RVCLQPIRGVEGSDY | 1721 | Q13332 | |
| ILCRYQETGSIRPGA | 86 | P23760 | |
| GRGCLIPNQGYLSEA | 176 | Q8TCG2 | |
| QNTGVADGYPVRLEC | 1241 | Q8WX93 | |
| AGYQTRGCSQPERVK | 466 | Q8NA29 | |
| GRALYAVAQRCLPSN | 71 | Q96EF6 | |
| RACVRYGINPEQIQG | 176 | Q86VR8 | |
| IPCYTLDGDNIRQGL | 81 | O43252 | |
| LLPLRGQANTGCYGI | 21 | P02747 | |
| ILRESQRQPGCYTLA | 81 | P52757 | |
| QRQPGCYTLALRFGN | 86 | P52757 | |
| ILGRYCGNTIPDSID | 2406 | O60494 | |
| PNAQCEEGYVRARIA | 201 | Q9H3Q3 | |
| DLRANCEPQTYGIGL | 261 | Q16134 | |
| YGLSCQRDPNTGRLN | 1501 | P04114 | |
| IRRTEPLQTNCAYVG | 136 | O15072 | |
| VGIECPDYRGNRLST | 521 | Q7L8L6 | |
| LFRAEGYPVSIGCNV | 31 | Q93033 | |
| IRYAGRPLQCLIQDG | 256 | O75398 | |
| DRGLYTIAQCCPELR | 201 | Q9UJT9 | |
| NVTGPQIRDGGVYRC | 471 | Q8TD84 | |
| RCSVQNGLLGCYPDR | 846 | Q9Y6R7 | |
| YCRVQALSVVGAGPF | 826 | Q9Y2H6 | |
| LECTVGNLLPGTVYR | 726 | Q53EP0 | |
| EGGLCRRCYSPAQEN | 1786 | Q9P0X4 | |
| QLPTCGDQVYSVRRR | 586 | Q9BY84 | |
| GQLGRELRAQECLPY | 51 | P23610 | |
| LDRNLSCRVVGVPYQ | 246 | P05154 | |
| EGYSLIGNPVARCGE | 601 | P10643 | |
| GQYKRCGVTSVPDIR | 296 | Q9H0C8 | |
| NYNDLCPPIGRRAAT | 16 | O95467 | |
| QLVRGEPNVSYICSR | 206 | P49841 | |
| YSRCLQACGQERGPV | 771 | Q92771 | |
| GEGCAQRERPGVYTN | 596 | P03951 | |
| LNPDGVIVGNYRCSL | 501 | Q5U5Z8 | |
| AGLTRNYCRNPDAEI | 1096 | P08519 | |
| GGLTRNYCRNPDAEI | 1316 | P08519 | |
| CDSENRYVGNPLRGT | 1091 | Q5VV63 | |
| RPRGLLGRCYLNTVN | 546 | Q14767 | |
| CQGLAPGTEVTYRLQ | 271 | P42701 | |
| PGLYSRIQEFACRGQ | 311 | Q9NTJ4 | |
| RLSYRAAGNECPELQ | 291 | P48740 | |
| GQGIKCDIPRYIVSQ | 451 | Q6P0Q8 | |
| ICGAQRCENTPGSYR | 1016 | Q8N2S1 | |
| SVINPGAIYRCRIGK | 81 | P13612 | |
| GAIYRCRIGKNPGQT | 86 | P13612 | |
| GCARREQPGVYTKVA | 601 | P03952 | |
| VGGQAPKAIRSVECY | 306 | Q9UH77 | |
| IRQCPDRTYGDVATG | 516 | Q13751 | |
| PRQTNYIRSLGCGNT | 86 | Q3LI76 | |
| AYLQIQSPAGQSRCG | 36 | P08311 | |
| GRTAGYDPNLDNCLV | 226 | Q5D0E6 | |
| AAYEQDLLPGGCTLR | 636 | Q9H078 | |
| YGDVFQIRLGSCPIV | 81 | Q16678 | |
| RIVCPYANGIDINCG | 101 | O95620 | |
| CPEQVVGGIYGVLNR | 751 | P13639 | |
| NELIPDGYNRCLVAG | 511 | Q8WYP5 | |
| GRDCRNNLYLLPTGE | 231 | O00423 | |
| LEQICRPIFSRLYGG | 601 | P17066 | |
| EVQTPGVYRCQTRGA | 76 | Q6BAA4 | |
| GVYRCQTRGAPVSDP | 81 | Q6BAA4 | |
| DCIRQVQPEGPYRVA | 2291 | P49327 | |
| VYIIQACRGEQRDPG | 126 | P31944 | |
| LYLVGGAQGRRCEAP | 81 | Q15768 | |
| GGLYGAPRILQCIAQ | 326 | A0AV02 | |
| PPEVVRLYNANGICG | 76 | B5MCN3 | |
| ERQYLLCPGSSGVEN | 221 | Q9NVU0 | |
| RYVNRQGQVCGQSPP | 101 | Q9P1Z2 | |
| GVNRPTISCIFDYGN | 1136 | O75923 | |
| DAQILPSRVQGGCYR | 126 | Q6PGQ1 | |
| AAQQGGYEIPARLRT | 201 | Q07866 | |
| GVRNLSVPLYCSGNG | 2321 | Q3ZCN5 | |
| NRLSLDLYPGGCQQL | 36 | Q9HB75 | |
| QPVGRARHSLCELYG | 1286 | Q96Q06 | |
| EVCIQLTGRGCGYRP | 966 | Q9NZ71 | |
| CVPRVVAEYLNGAVR | 71 | Q8N983 | |
| GQRAGTCVLEYATPL | 251 | Q86WV6 | |
| RRYPNVFGIGDCTNL | 326 | Q9Y6N5 | |
| PDTGSVYVLRVRGCN | 496 | Q7Z4K8 | |
| EGCAQPNRPGIYTRV | 246 | Q15661 | |
| EGCAQPNRPGIYTRV | 246 | P20231 | |
| APQSPAVYARIGRIC | 286 | Q13275 | |
| RQRYVPGDTVRQLCN | 531 | A2VEC9 | |
| QVCREAGCPAGRLYR | 3691 | A2VEC9 | |
| VTAQFPGACGLRYRN | 31 | Q13148 | |
| QRRLGIFPANYVAPC | 86 | Q5TCX8 | |
| GIACLQPRAAARDYT | 716 | O14513 | |
| CSGSAGYPERLIQQR | 451 | Q5HYW2 | |
| LTPAIQRYVQGFCRG | 241 | O14841 | |
| YHQLLERCVRAPGSG | 211 | P58107 | |
| GRCINQTEGDLPLNY | 1361 | Q14524 | |
| PFQCPRRGEGAALQY | 21 | A6NKW6 | |
| VQSRTPQGGLYNRPC | 416 | Q8NDZ2 | |
| LTLARNCFQLYPVGG | 336 | Q9UQ13 | |
| LCVPERSLASYGVRQ | 276 | Q9H0F6 | |
| CTIRYRQTGPLIGRQ | 2011 | Q9UKZ4 | |
| QIRGCGASYPTSQER | 541 | Q6ZUB1 | |
| GIYICSPTNVIEGNR | 2321 | P08F94 | |
| VACYNGGRVIRLDPV | 216 | Q15493 | |
| QCNTITAPGDLRRIY | 551 | Q5VTB9 | |
| PCRGNTLSRIYVEND | 176 | P08514 | |
| ATYQGVVRGLCGPAI | 86 | A6NNN8 | |
| IGGYELQGSPARVCQ | 291 | P78539 | |
| PGRRSFRGCGQINYA | 196 | Q9UJM3 | |
| LYGCQRARGPPRESE | 256 | Q8TAY7 | |
| LRGPCQESFYNLGRG | 806 | Q9Y5Q9 | |
| GCRIGYSSPQTLADQ | 346 | O95573 | |
| GGIAVVSRNPQILYC | 211 | Q14865 | |
| NGGGDCYVPQRVIFL | 196 | Q8NA57 | |
| QPYRGIACARFIGNR | 171 | Q01973 | |
| LLIQVYGGPCSQSVR | 536 | Q12884 | |
| VPSYCLNARGEGAVR | 101 | Q9ULP9 | |
| QQYRCLYPGTVVRGL | 2236 | O15417 | |
| GRCPYASAQLVNLTR | 181 | Q8N8E2 | |
| LGTFLVRSQPGCYNR | 746 | Q7RTX0 | |
| VRSQPGCYNRARGLT | 751 | Q7RTX0 | |
| GGEDENRCVRLYGPN | 141 | O15393 | |
| ARIRQELGAVCYEPN | 381 | O00295 | |
| LRQQSECVSGNGPAY | 121 | A4D1E1 | |
| SPGERNQYICRLNRS | 1006 | Q6AWC2 | |
| LGLQRITGDYLCSPE | 66 | Q13432 | |
| QYLGVTSPECLQRTG | 1686 | Q6GYQ0 | |
| PGNRVAEGQVTCPYL | 241 | Q96DV4 | |
| FRCYLASLQGGELPN | 621 | Q13009 | |
| IINSDGGPYVCRATN | 271 | O15394 | |
| APGISYQRLVRAEQG | 136 | Q8WYR1 | |
| GTEVGCSNIAYPRLV | 356 | P31639 | |
| SLRCQNYGIPPVNRA | 826 | P41226 | |
| EGCARQNRPGVYIRV | 251 | Q9BQR3 | |
| SILRGCVPGVYRVQT | 346 | Q9H6E5 | |
| QDQPFRSDGRVIYCV | 986 | Q9HCF6 | |
| QICPGFVIQSRRYAG | 91 | Q9BSK1 | |
| AVRDPYGNRPLCIGR | 196 | Q06203 | |
| TVRYRCGQQLAIEAP | 301 | Q06203 | |
| AQAAAICEYPRRIQG | 216 | Q92626 | |
| PADAGRYECVARNTI | 586 | Q92626 | |
| PVCRSYGITSLQQEG | 146 | Q9H3T2 | |
| DAQRRQRPYVVTFCG | 411 | P08240 | |
| GDLYLQTGLSVDRPC | 911 | O15040 | |
| ARCPNGDLARRYGVT | 1326 | O15040 | |
| PATYGELQQRCRPDQ | 3326 | Q15149 | |
| GVAGGSVAVLCPYNR | 361 | P01833 | |
| SLGNVVDPRTCLNRY | 351 | Q96GW9 | |
| ANEDTPQLYVACGRG | 416 | Q15393 | |
| YDQCRIQVRLPDGTS | 211 | Q04323 | |
| LERAVPTGYIDVGNC | 51 | Q6ZNB5 | |
| YRDQVLGELRGCSAP | 46 | Q9UHR6 | |
| DYCGPLVEIARNRGC | 71 | Q9P272 | |
| EQCVPDRGQQYQGRL | 211 | P00734 | |
| RQFCYQETPGPREAL | 56 | Q6R2W3 | |
| GVPRAKALCNYRGQN | 126 | Q8TEC5 | |
| KALCNYRGQNPGDLR | 131 | Q8TEC5 | |
| VIRGPAGNNDCRIYV | 6 | Q07955 | |
| RYCVRPNSGIIDAGA | 51 | O95292 | |
| RQLCYQETPGPREAL | 56 | O15535 | |
| VCGGANRLSVYRLQL | 206 | Q2TBF2 | |
| FCNQYGARLSLRQPG | 996 | Q6ZS17 | |
| VRPRNAGIYRCIGQG | 291 | Q13308 | |
| LDAGQPRQALGYCSL | 401 | A8MYJ7 | |
| DPQLRAARCLAEQGY | 141 | Q5TAA0 | |
| NCVRTILPVGIARYG | 2831 | Q6ZQQ6 | |
| YTRCGGPQQSRAERP | 381 | Q08ET2 | |
| NPTIGYCQGLNRLAA | 706 | Q9BYX2 | |
| ISQRTGCRGFLPENY | 321 | P57075 | |
| LGNIIGDGPQCRDYV | 181 | O00629 | |
| GDGPQCRDYVISLGV | 186 | O00629 | |
| EIYGECGVCPRGQRT | 26 | Q9P055 | |
| GNPITAYTIERCQGE | 401 | Q5VTT5 | |
| RCPIQGLVEGQSYRF | 431 | Q5VTT5 |